<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:778033de-956c-4b5d-a8a3-d666791c6d0f,g:ce06bd80-0783-4e34-aed8-37c9947f8bff-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://c4therapeutics.com/role/Cover" xlink:type="simple" xlink:href="cccc-20221231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b09b39cc-f308-4997-a0a2-6aa3f21fb665" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_DocumentType_b09b39cc-f308-4997-a0a2-6aa3f21fb665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_e72ce7cd-00d1-4eda-ad6a-12e8baba09cb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_DocumentAnnualReport_e72ce7cd-00d1-4eda-ad6a-12e8baba09cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ab516d9a-eb74-4776-8be6-be774bae7ce0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_DocumentPeriodEndDate_ab516d9a-eb74-4776-8be6-be774bae7ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_82527a1f-e6be-45b0-9505-598379031940" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_CurrentFiscalYearEndDate_82527a1f-e6be-45b0-9505-598379031940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_09829511-345b-4705-a689-c8a62b394f70" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_DocumentFiscalYearFocus_09829511-345b-4705-a689-c8a62b394f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_5b8020e2-50f0-440a-836d-5ce675611e8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_5b8020e2-50f0-440a-836d-5ce675611e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_df781872-31ad-4610-88cd-9cd4851cbd8c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_DocumentTransitionReport_df781872-31ad-4610-88cd-9cd4851cbd8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_73614b06-442e-4d79-81c9-9d23979f10ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityFileNumber_73614b06-442e-4d79-81c9-9d23979f10ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_df5ba87d-282a-44e1-ab26-62939c2e5d6e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityRegistrantName_df5ba87d-282a-44e1-ab26-62939c2e5d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3b6e23e3-bbf8-4ff7-85cd-57d44904f1bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3b6e23e3-bbf8-4ff7-85cd-57d44904f1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b3ffd11d-ebb1-4377-901c-add1da8f4cc8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityTaxIdentificationNumber_b3ffd11d-ebb1-4377-901c-add1da8f4cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7d79f6c1-251c-4e5d-a1b8-b88cb16f091f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityAddressAddressLine1_7d79f6c1-251c-4e5d-a1b8-b88cb16f091f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_de6bbef8-1e6b-48ee-a367-2b86e48ea72e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityAddressAddressLine2_de6bbef8-1e6b-48ee-a367-2b86e48ea72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_f807a9e8-b538-40a2-b894-403e846cfe65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityAddressCityOrTown_f807a9e8-b538-40a2-b894-403e846cfe65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2c61b0a1-8815-4935-a48b-ca59dbeabc6a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityAddressStateOrProvince_2c61b0a1-8815-4935-a48b-ca59dbeabc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d9cb7e93-596f-4749-a716-d0410f7c78ec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityAddressPostalZipCode_d9cb7e93-596f-4749-a716-d0410f7c78ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_63426711-cde9-4081-b48f-0e729b397279" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_CityAreaCode_63426711-cde9-4081-b48f-0e729b397279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d1950750-098f-4e82-b3e1-226c0fc2f0e3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_LocalPhoneNumber_d1950750-098f-4e82-b3e1-226c0fc2f0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_af920bce-d3ad-46bb-ab60-b3dad5879a10" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_Security12bTitle_af920bce-d3ad-46bb-ab60-b3dad5879a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_02fca753-8621-4843-8471-30d98d9ff51d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_TradingSymbol_02fca753-8621-4843-8471-30d98d9ff51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_7fe7594d-81b2-4465-a268-704db2be2fc3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_SecurityExchangeName_7fe7594d-81b2-4465-a268-704db2be2fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_b28a1e65-8b11-48dc-9b07-5ea5c72d1656" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_b28a1e65-8b11-48dc-9b07-5ea5c72d1656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_70579b23-1f81-4d6b-85e2-92d2c18d906c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityVoluntaryFilers_70579b23-1f81-4d6b-85e2-92d2c18d906c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c65a14c3-2141-484e-b336-6f5b79eb8261" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityCurrentReportingStatus_c65a14c3-2141-484e-b336-6f5b79eb8261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9b69ee44-8309-4675-b187-7df2237da19e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityInteractiveDataCurrent_9b69ee44-8309-4675-b187-7df2237da19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_afcde8e7-01c7-4aba-834c-d418115942ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityFilerCategory_afcde8e7-01c7-4aba-834c-d418115942ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_7c1e2f46-5dda-4be8-83d8-d55f478f31a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntitySmallBusiness_7c1e2f46-5dda-4be8-83d8-d55f478f31a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d5532c40-4a39-4845-8098-acf50d09e2ca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityEmergingGrowthCompany_d5532c40-4a39-4845-8098-acf50d09e2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_f1add543-c86b-4db7-8cf1-fee05c4474dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_IcfrAuditorAttestationFlag_f1add543-c86b-4db7-8cf1-fee05c4474dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_1f91ed08-7205-4ef0-8938-b1e9e2f07f8d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityShellCompany_1f91ed08-7205-4ef0-8938-b1e9e2f07f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_93bd84e9-2200-424b-845f-095ad9cbf8c8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityPublicFloat_93bd84e9-2200-424b-845f-095ad9cbf8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_f7eed73c-2085-4d2d-b84f-bd7f9ef41bcd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_f7eed73c-2085-4d2d-b84f-bd7f9ef41bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_3e1cfa90-2802-468b-9030-d5052f30d13e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_AmendmentFlag_3e1cfa90-2802-468b-9030-d5052f30d13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_270be9a3-1d17-4eee-afb1-91c2b28bb521" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_EntityCentralIndexKey_270be9a3-1d17-4eee-afb1-91c2b28bb521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_cbf01298-1d4b-4310-8cfd-caaf47af82e0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_3b4f2334-9fde-4ad7-918c-08ce1150811a" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_cbf01298-1d4b-4310-8cfd-caaf47af82e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/AuditInformation" xlink:type="simple" xlink:href="cccc-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AuditInformationAbstract_a269330e-b73a-458b-bf23-7f85d5b55396" xlink:href="cccc-20221231.xsd#cccc_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_1a8f52e7-82fc-4d1d-9106-04c2b706ecc8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_AuditInformationAbstract_a269330e-b73a-458b-bf23-7f85d5b55396" xlink:to="loc_dei_AuditorFirmId_1a8f52e7-82fc-4d1d-9106-04c2b706ecc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_4a14a9a0-5123-48ad-a76b-eb9e4d3ecae8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_AuditInformationAbstract_a269330e-b73a-458b-bf23-7f85d5b55396" xlink:to="loc_dei_AuditorName_4a14a9a0-5123-48ad-a76b-eb9e4d3ecae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_5a55048e-9d97-451f-a998-c49fce9eaff8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_AuditInformationAbstract_a269330e-b73a-458b-bf23-7f85d5b55396" xlink:to="loc_dei_AuditorLocation_5a55048e-9d97-451f-a998-c49fce9eaff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cccc-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c48005aa-e5d7-421c-809d-ba0955da39ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8e8f804a-52c5-40cd-9eaf-4ecaf151303d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c48005aa-e5d7-421c-809d-ba0955da39ac" xlink:to="loc_us-gaap_AssetsAbstract_8e8f804a-52c5-40cd-9eaf-4ecaf151303d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_92c66566-f50a-4efe-aeea-babe92fabd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e8f804a-52c5-40cd-9eaf-4ecaf151303d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_92c66566-f50a-4efe-aeea-babe92fabd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0e21ce48-dfe4-400f-850c-cef68c62b8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_92c66566-f50a-4efe-aeea-babe92fabd9f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0e21ce48-dfe4-400f-850c-cef68c62b8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_785bfe0f-f03a-4845-85db-638a46e4a484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_92c66566-f50a-4efe-aeea-babe92fabd9f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_785bfe0f-f03a-4845-85db-638a46e4a484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1243b755-f4ed-4e5a-8838-223152f8b62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_92c66566-f50a-4efe-aeea-babe92fabd9f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1243b755-f4ed-4e5a-8838-223152f8b62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0e91a8e2-9aa6-4e4b-ace9-23ede9fd2bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_92c66566-f50a-4efe-aeea-babe92fabd9f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0e91a8e2-9aa6-4e4b-ace9-23ede9fd2bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d688a66f-af1b-46ee-b1a1-865b902cfdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_92c66566-f50a-4efe-aeea-babe92fabd9f" xlink:to="loc_us-gaap_AssetsCurrent_d688a66f-af1b-46ee-b1a1-865b902cfdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_7cebd863-452b-4912-b6e1-848cac3fc1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e8f804a-52c5-40cd-9eaf-4ecaf151303d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_7cebd863-452b-4912-b6e1-848cac3fc1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_71ce7037-1554-402f-9a7b-2595a28b865e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e8f804a-52c5-40cd-9eaf-4ecaf151303d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_71ce7037-1554-402f-9a7b-2595a28b865e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8de747bd-9362-4ddc-af49-06d5fc5a2111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e8f804a-52c5-40cd-9eaf-4ecaf151303d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8de747bd-9362-4ddc-af49-06d5fc5a2111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_3fa98941-c89e-4357-a978-af5d0890849d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e8f804a-52c5-40cd-9eaf-4ecaf151303d" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_3fa98941-c89e-4357-a978-af5d0890849d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6c903e90-06fd-4ee7-841b-a39a30e60546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e8f804a-52c5-40cd-9eaf-4ecaf151303d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6c903e90-06fd-4ee7-841b-a39a30e60546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_db961406-b280-4794-9f46-c5d0ed0bf5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e8f804a-52c5-40cd-9eaf-4ecaf151303d" xlink:to="loc_us-gaap_Assets_db961406-b280-4794-9f46-c5d0ed0bf5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e75ff74-880f-420f-a98e-006445fa9c11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c48005aa-e5d7-421c-809d-ba0955da39ac" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e75ff74-880f-420f-a98e-006445fa9c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_61376abf-d23e-4a9c-b363-27f9d2e76639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e75ff74-880f-420f-a98e-006445fa9c11" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_61376abf-d23e-4a9c-b363-27f9d2e76639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d46b101b-ab11-4268-8f1b-727be4e0353b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_61376abf-d23e-4a9c-b363-27f9d2e76639" xlink:to="loc_us-gaap_AccountsPayableCurrent_d46b101b-ab11-4268-8f1b-727be4e0353b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_0b13b224-f3ad-44dd-814a-327710c0a3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_61376abf-d23e-4a9c-b363-27f9d2e76639" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_0b13b224-f3ad-44dd-814a-327710c0a3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0f9641b2-3221-43ce-a03c-777199379aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_61376abf-d23e-4a9c-b363-27f9d2e76639" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0f9641b2-3221-43ce-a03c-777199379aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e51b1b26-8b52-4285-a81a-02cf799190c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_61376abf-d23e-4a9c-b363-27f9d2e76639" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e51b1b26-8b52-4285-a81a-02cf799190c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8d3773c8-64ec-4f4d-ac8a-ee7039b62264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_61376abf-d23e-4a9c-b363-27f9d2e76639" xlink:to="loc_us-gaap_LongTermDebtCurrent_8d3773c8-64ec-4f4d-ac8a-ee7039b62264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_91f54eb2-b967-4e21-aecb-a91229059d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_61376abf-d23e-4a9c-b363-27f9d2e76639" xlink:to="loc_us-gaap_LiabilitiesCurrent_91f54eb2-b967-4e21-aecb-a91229059d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f143c927-0472-48c6-9285-e45512ce3511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e75ff74-880f-420f-a98e-006445fa9c11" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f143c927-0472-48c6-9285-e45512ce3511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e96f4d67-3c4c-4573-ac30-6fcc68c6ac9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e75ff74-880f-420f-a98e-006445fa9c11" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e96f4d67-3c4c-4573-ac30-6fcc68c6ac9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_0a964817-28a7-45e9-a220-f8bff17bc422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e75ff74-880f-420f-a98e-006445fa9c11" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_0a964817-28a7-45e9-a220-f8bff17bc422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9537fa00-89c5-420f-83f8-2862ca8e1bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e75ff74-880f-420f-a98e-006445fa9c11" xlink:to="loc_us-gaap_Liabilities_9537fa00-89c5-420f-83f8-2862ca8e1bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_87f0c274-de87-4085-a4f7-1fe82fe2951c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e75ff74-880f-420f-a98e-006445fa9c11" xlink:to="loc_us-gaap_CommitmentsAndContingencies_87f0c274-de87-4085-a4f7-1fe82fe2951c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2e7e04c7-6e45-4bfe-ba13-f635f441bd64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e75ff74-880f-420f-a98e-006445fa9c11" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2e7e04c7-6e45-4bfe-ba13-f635f441bd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ffae373f-db00-4411-9b96-5808a265f4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2e7e04c7-6e45-4bfe-ba13-f635f441bd64" xlink:to="loc_us-gaap_PreferredStockValue_ffae373f-db00-4411-9b96-5808a265f4c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f45cc287-19d2-4b1c-9bbc-0ebe50ccac61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2e7e04c7-6e45-4bfe-ba13-f635f441bd64" xlink:to="loc_us-gaap_CommonStockValue_f45cc287-19d2-4b1c-9bbc-0ebe50ccac61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a929f88a-7510-4bda-b37c-0e1981534afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2e7e04c7-6e45-4bfe-ba13-f635f441bd64" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_a929f88a-7510-4bda-b37c-0e1981534afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c260a961-e485-41b1-9a03-3fc52c5a83b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2e7e04c7-6e45-4bfe-ba13-f635f441bd64" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c260a961-e485-41b1-9a03-3fc52c5a83b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7cd4355b-6300-4f3a-b317-097c9d1d2526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2e7e04c7-6e45-4bfe-ba13-f635f441bd64" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7cd4355b-6300-4f3a-b317-097c9d1d2526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b4c0ef27-e09e-420b-8b7f-d3cb86cf182e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2e7e04c7-6e45-4bfe-ba13-f635f441bd64" xlink:to="loc_us-gaap_StockholdersEquity_b4c0ef27-e09e-420b-8b7f-d3cb86cf182e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_da9dcd97-40e3-4bda-b58d-82c0c9ce4fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e75ff74-880f-420f-a98e-006445fa9c11" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_da9dcd97-40e3-4bda-b58d-82c0c9ce4fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cccc-20221231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_813f4bc9-c1b1-4649-a75f-9772217827e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5ba41cbe-c096-4d03-9627-0d9d4fa3b354" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_813f4bc9-c1b1-4649-a75f-9772217827e8" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5ba41cbe-c096-4d03-9627-0d9d4fa3b354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ed42e612-8127-47c8-ab24-399b457a30c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_813f4bc9-c1b1-4649-a75f-9772217827e8" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ed42e612-8127-47c8-ab24-399b457a30c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_a8de56b9-e8bb-4177-8396-6ec02c422e65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_813f4bc9-c1b1-4649-a75f-9772217827e8" xlink:to="loc_us-gaap_PreferredStockSharesIssued_a8de56b9-e8bb-4177-8396-6ec02c422e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_fbf765e1-3f31-4b72-ae34-a34cfb33acec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_813f4bc9-c1b1-4649-a75f-9772217827e8" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_fbf765e1-3f31-4b72-ae34-a34cfb33acec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_49aee135-2355-480c-9257-6e98edbaedcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_813f4bc9-c1b1-4649-a75f-9772217827e8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_49aee135-2355-480c-9257-6e98edbaedcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5d04930d-5a40-41cd-958b-f9d57f1c23a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_813f4bc9-c1b1-4649-a75f-9772217827e8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5d04930d-5a40-41cd-958b-f9d57f1c23a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_54b2a634-c69f-4cc8-b34a-df8973117bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_813f4bc9-c1b1-4649-a75f-9772217827e8" xlink:to="loc_us-gaap_CommonStockSharesIssued_54b2a634-c69f-4cc8-b34a-df8973117bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cde6571a-198b-4989-b5af-865841ca444e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_813f4bc9-c1b1-4649-a75f-9772217827e8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cde6571a-198b-4989-b5af-865841ca444e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="cccc-20221231.xsd#ConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6f4ec48f-2ac0-42bb-95d0-89bdccd9c7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6f4ec48f-2ac0-42bb-95d0-89bdccd9c7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a9ef3e4d-db64-4718-86c1-cd3e92ca68b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a9ef3e4d-db64-4718-86c1-cd3e92ca68b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_99cde090-12a2-47c7-a772-3bcebcea4a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a9ef3e4d-db64-4718-86c1-cd3e92ca68b3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_99cde090-12a2-47c7-a772-3bcebcea4a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_a760879d-c370-425e-ab03-98e51c5fda07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a9ef3e4d-db64-4718-86c1-cd3e92ca68b3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_a760879d-c370-425e-ab03-98e51c5fda07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7b8739c3-cca3-4594-becb-ee9c7f94416d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a9ef3e4d-db64-4718-86c1-cd3e92ca68b3" xlink:to="loc_us-gaap_OperatingExpenses_7b8739c3-cca3-4594-becb-ee9c7f94416d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_faeb3549-34f4-4c88-9b69-2138a6105476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_OperatingIncomeLoss_faeb3549-34f4-4c88-9b69-2138a6105476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c005bb2f-732d-4ba5-ba87-5d258ddea575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c005bb2f-732d-4ba5-ba87-5d258ddea575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_InterestExpenseAndAmortizationLongTermDebtRelatedParty_926c8074-4efb-49b7-ab0a-0da6028be368" xlink:href="cccc-20221231.xsd#cccc_InterestExpenseAndAmortizationLongTermDebtRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c005bb2f-732d-4ba5-ba87-5d258ddea575" xlink:to="loc_cccc_InterestExpenseAndAmortizationLongTermDebtRelatedParty_926c8074-4efb-49b7-ab0a-0da6028be368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_7c2fffa4-d321-475a-a091-64d6fafece71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c005bb2f-732d-4ba5-ba87-5d258ddea575" xlink:to="loc_us-gaap_InterestAndOtherIncome_7c2fffa4-d321-475a-a091-64d6fafece71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c90c128f-b994-4742-96b0-32627cf67fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_c005bb2f-732d-4ba5-ba87-5d258ddea575" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_c90c128f-b994-4742-96b0-32627cf67fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c12a882b-7b0f-4b33-9152-31310d3e1d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_NetIncomeLoss_c12a882b-7b0f-4b33-9152-31310d3e1d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b05d094e-0e5d-4f7b-8b8a-1e3c9e368c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_EarningsPerShareBasic_b05d094e-0e5d-4f7b-8b8a-1e3c9e368c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_ece5fe28-3d71-43d9-b5e5-fc1cf1726ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_ece5fe28-3d71-43d9-b5e5-fc1cf1726ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b398a131-d634-438e-a9c3-b8c2d8d396e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b398a131-d634-438e-a9c3-b8c2d8d396e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c590ba81-a890-4fda-b0ba-b91506580e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c590ba81-a890-4fda-b0ba-b91506580e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_93d280ee-c49d-4e50-a11b-193c6c8ec3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_93d280ee-c49d-4e50-a11b-193c6c8ec3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_adecc127-fb19-4a50-8e6b-9dad0761e23d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_93d280ee-c49d-4e50-a11b-193c6c8ec3fe" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_adecc127-fb19-4a50-8e6b-9dad0761e23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8918e538-fb96-48a2-94ee-ef4d8355050a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_93d280ee-c49d-4e50-a11b-193c6c8ec3fe" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_8918e538-fb96-48a2-94ee-ef4d8355050a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_6d19d7a1-3f6c-4296-b70d-ae7c2d901777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_55fddbe2-4726-42c1-a588-11caa53abceb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_6d19d7a1-3f6c-4296-b70d-ae7c2d901777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="cccc-20221231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d7225555-907f-4635-a3ce-6f91856ad7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9cdd4fbb-24aa-48ba-b904-5e610acf003d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d7225555-907f-4635-a3ce-6f91856ad7e0" xlink:to="loc_us-gaap_StatementTable_9cdd4fbb-24aa-48ba-b904-5e610acf003d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5d897111-3b6e-453d-8c5e-a3127a450d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9cdd4fbb-24aa-48ba-b904-5e610acf003d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5d897111-3b6e-453d-8c5e-a3127a450d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_504228d7-60ee-448c-bb7c-9354dd14dc59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5d897111-3b6e-453d-8c5e-a3127a450d0d" xlink:to="loc_us-gaap_EquityComponentDomain_504228d7-60ee-448c-bb7c-9354dd14dc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_df7bf5d5-96c9-4956-ae14-2ddc472b9a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_504228d7-60ee-448c-bb7c-9354dd14dc59" xlink:to="loc_us-gaap_CommonStockMember_df7bf5d5-96c9-4956-ae14-2ddc472b9a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_09af122f-13ab-4a87-90fe-f3b16578d445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_504228d7-60ee-448c-bb7c-9354dd14dc59" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_09af122f-13ab-4a87-90fe-f3b16578d445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1e458060-a97a-4a02-a52e-b650c72eb55b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_504228d7-60ee-448c-bb7c-9354dd14dc59" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1e458060-a97a-4a02-a52e-b650c72eb55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_23acb38f-9e46-4c02-bfbf-0a527def6ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_504228d7-60ee-448c-bb7c-9354dd14dc59" xlink:to="loc_us-gaap_RetainedEarningsMember_23acb38f-9e46-4c02-bfbf-0a527def6ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0b1d4d08-4709-4ce0-9620-4fa93ab55718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9cdd4fbb-24aa-48ba-b904-5e610acf003d" xlink:to="loc_us-gaap_StatementLineItems_0b1d4d08-4709-4ce0-9620-4fa93ab55718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0b1d4d08-4709-4ce0-9620-4fa93ab55718" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_41be0533-5190-4eeb-baf4-50c058371d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_SharesOutstanding_41be0533-5190-4eeb-baf4-50c058371d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f27694aa-c5d0-4b9b-86e2-ee3ee78cbaec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_StockholdersEquity_f27694aa-c5d0-4b9b-86e2-ee3ee78cbaec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4ba951ca-a62a-4c14-9b1d-3faf2948c4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4ba951ca-a62a-4c14-9b1d-3faf2948c4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_9981f51a-b97e-461b-bc0b-76c831363da3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_9981f51a-b97e-461b-bc0b-76c831363da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_StockIssuedDuringPeriodSharesWarrantExercisedRelatedParty_eb95a74f-f7a6-40b7-bca9-b6feb2d62117" xlink:href="cccc-20221231.xsd#cccc_StockIssuedDuringPeriodSharesWarrantExercisedRelatedParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_cccc_StockIssuedDuringPeriodSharesWarrantExercisedRelatedParty_eb95a74f-f7a6-40b7-bca9-b6feb2d62117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e111634c-008e-47c9-86e9-7fa7bf4cabcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e111634c-008e-47c9-86e9-7fa7bf4cabcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b72ab694-501d-4dd5-8199-81f0c32ecf16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_b72ab694-501d-4dd5-8199-81f0c32ecf16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_062b8bdd-527e-486b-9ddf-85b65ecfac7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_062b8bdd-527e-486b-9ddf-85b65ecfac7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1af22c51-fb5c-46d4-8980-ac6dd0740c10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1af22c51-fb5c-46d4-8980-ac6dd0740c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8012d433-6f26-4ba9-8fa1-96df7a363255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_8012d433-6f26-4ba9-8fa1-96df7a363255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_43d78eb5-ee15-4ff3-99fb-94b950b1ed99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_43d78eb5-ee15-4ff3-99fb-94b950b1ed99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_20ec980f-2e76-4d73-a7b5-566e8fb34ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_NetIncomeLoss_20ec980f-2e76-4d73-a7b5-566e8fb34ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AdjustmentsToAdditionalPaidInCapitalOtherShares_7f408a63-4dc9-4ee4-8da5-dc8e882b7b03" xlink:href="cccc-20221231.xsd#cccc_AdjustmentsToAdditionalPaidInCapitalOtherShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_cccc_AdjustmentsToAdditionalPaidInCapitalOtherShares_7f408a63-4dc9-4ee4-8da5-dc8e882b7b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_4c60f98d-1fc8-4d57-bc54-cf6b18beab72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_4c60f98d-1fc8-4d57-bc54-cf6b18beab72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_5575ee48-bc37-448d-bb35-83720af6112b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_SharesOutstanding_5575ee48-bc37-448d-bb35-83720af6112b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_dc9e4fcb-bef1-49ae-871e-97732246ef09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a0ffe209-ef22-484b-9ea3-f4387b1512b7" xlink:to="loc_us-gaap_StockholdersEquity_dc9e4fcb-bef1-49ae-871e-97732246ef09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="simple" xlink:href="cccc-20221231.xsd#ConsolidatedStatementsofStockholdersEquityParenthetical"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedStatementsofStockholdersEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_e90a2667-fae1-4259-b116-46d007bccbe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_f0d72956-ddfa-443a-b7c4-ee78ea6b2cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_e90a2667-fae1-4259-b116-46d007bccbe8" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_f0d72956-ddfa-443a-b7c4-ee78ea6b2cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cccc-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d887d480-50cf-4aa6-8e70-af60a67d083d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7190943-2be0-4b74-a44b-b0a5ed876d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d887d480-50cf-4aa6-8e70-af60a67d083d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7190943-2be0-4b74-a44b-b0a5ed876d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c73febae-1637-46d7-89c2-92af69265f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7190943-2be0-4b74-a44b-b0a5ed876d2d" xlink:to="loc_us-gaap_NetIncomeLoss_c73febae-1637-46d7-89c2-92af69265f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce6fd40e-4e2b-4547-8631-2f28877f41be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7190943-2be0-4b74-a44b-b0a5ed876d2d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce6fd40e-4e2b-4547-8631-2f28877f41be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c9569407-0a74-4ea1-aca7-8c512fb45907" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce6fd40e-4e2b-4547-8631-2f28877f41be" xlink:to="loc_us-gaap_ShareBasedCompensation_c9569407-0a74-4ea1-aca7-8c512fb45907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_b2cba23d-dc68-4feb-bba6-2c60edc5c279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce6fd40e-4e2b-4547-8631-2f28877f41be" xlink:to="loc_us-gaap_DepreciationAndAmortization_b2cba23d-dc68-4feb-bba6-2c60edc5c279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_8ea8d6bc-f8fd-416b-8e64-8a5a69c1ab75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce6fd40e-4e2b-4547-8631-2f28877f41be" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_8ea8d6bc-f8fd-416b-8e64-8a5a69c1ab75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_e22274ce-96bc-4792-9226-993cd83783e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce6fd40e-4e2b-4547-8631-2f28877f41be" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_e22274ce-96bc-4792-9226-993cd83783e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_3c2686b6-3edf-4dc8-af1f-12ab4e431864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce6fd40e-4e2b-4547-8631-2f28877f41be" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_3c2686b6-3edf-4dc8-af1f-12ab4e431864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3efb22a8-feb4-42ae-b330-abde3048d6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ce6fd40e-4e2b-4547-8631-2f28877f41be" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3efb22a8-feb4-42ae-b330-abde3048d6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_42ad213b-1e37-4b9d-b820-1ac454119a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3efb22a8-feb4-42ae-b330-abde3048d6e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_42ad213b-1e37-4b9d-b820-1ac454119a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_445265dc-edd7-4c53-991c-a747482179c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3efb22a8-feb4-42ae-b330-abde3048d6e0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_445265dc-edd7-4c53-991c-a747482179c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_28b0c1cb-ec32-4f38-98a5-13322ab5d153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3efb22a8-feb4-42ae-b330-abde3048d6e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_28b0c1cb-ec32-4f38-98a5-13322ab5d153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_43b0102d-52f4-477b-ae23-5788484c9964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3efb22a8-feb4-42ae-b330-abde3048d6e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_43b0102d-52f4-477b-ae23-5788484c9964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_b904007c-0d27-45dd-9fb6-5e3168949996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3efb22a8-feb4-42ae-b330-abde3048d6e0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_b904007c-0d27-45dd-9fb6-5e3168949996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_a50ccbf3-3964-4bae-858f-f613f161be75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3efb22a8-feb4-42ae-b330-abde3048d6e0" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_a50ccbf3-3964-4bae-858f-f613f161be75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d4fc225a-0ef2-48a9-b7cf-64228e7e4df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f7190943-2be0-4b74-a44b-b0a5ed876d2d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d4fc225a-0ef2-48a9-b7cf-64228e7e4df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2071586-8ad7-4c30-9947-ca3870eeb3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d887d480-50cf-4aa6-8e70-af60a67d083d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2071586-8ad7-4c30-9947-ca3870eeb3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_318064ca-063e-49aa-8245-8fb99740d4f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2071586-8ad7-4c30-9947-ca3870eeb3b3" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_318064ca-063e-49aa-8245-8fb99740d4f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a04f8c92-4bf6-46c6-8e1f-6829ff9af91f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2071586-8ad7-4c30-9947-ca3870eeb3b3" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a04f8c92-4bf6-46c6-8e1f-6829ff9af91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_84f2c5ab-d093-4a51-9a90-677918640a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2071586-8ad7-4c30-9947-ca3870eeb3b3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_84f2c5ab-d093-4a51-9a90-677918640a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e580873-7ab4-4577-94a1-4fc3adab99b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2071586-8ad7-4c30-9947-ca3870eeb3b3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1e580873-7ab4-4577-94a1-4fc3adab99b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19030e24-988c-4e3e-98ce-e84bb01dbe99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d887d480-50cf-4aa6-8e70-af60a67d083d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19030e24-988c-4e3e-98ce-e84bb01dbe99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ProceedsFromIssuanceOfFollowOnOffering_9c68fbe6-6cf7-4f55-9e54-b034f3653ead" xlink:href="cccc-20221231.xsd#cccc_ProceedsFromIssuanceOfFollowOnOffering"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19030e24-988c-4e3e-98ce-e84bb01dbe99" xlink:to="loc_cccc_ProceedsFromIssuanceOfFollowOnOffering_9c68fbe6-6cf7-4f55-9e54-b034f3653ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_321b1479-9653-4bf5-835e-b46f2fea9dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19030e24-988c-4e3e-98ce-e84bb01dbe99" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_321b1479-9653-4bf5-835e-b46f2fea9dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_62107d58-6a71-4fe9-8cb8-1957ca3a0bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfInitialPublicOffering"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19030e24-988c-4e3e-98ce-e84bb01dbe99" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfInitialPublicOffering_62107d58-6a71-4fe9-8cb8-1957ca3a0bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5540056f-5d4d-4851-9d23-79d1ad5f41db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19030e24-988c-4e3e-98ce-e84bb01dbe99" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5540056f-5d4d-4851-9d23-79d1ad5f41db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd277a27-d670-4d7a-b32a-7ad0cf08b920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19030e24-988c-4e3e-98ce-e84bb01dbe99" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd277a27-d670-4d7a-b32a-7ad0cf08b920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d108ab6a-c9f9-45ad-9eb2-75816c9139b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d887d480-50cf-4aa6-8e70-af60a67d083d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d108ab6a-c9f9-45ad-9eb2-75816c9139b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_771b2796-fe85-4f6d-ad58-dc5b5da47827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d887d480-50cf-4aa6-8e70-af60a67d083d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_771b2796-fe85-4f6d-ad58-dc5b5da47827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d825627a-3f2c-4b36-8519-1a911ad81011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d887d480-50cf-4aa6-8e70-af60a67d083d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d825627a-3f2c-4b36-8519-1a911ad81011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_561f07dc-1fb1-4969-bfa0-b888e5a850c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d887d480-50cf-4aa6-8e70-af60a67d083d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_561f07dc-1fb1-4969-bfa0-b888e5a850c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c0cbd69a-9afe-46e4-a895-d2c88357771b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_561f07dc-1fb1-4969-bfa0-b888e5a850c8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c0cbd69a-9afe-46e4-a895-d2c88357771b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_0afb6ea4-5a72-454f-9ee3-d75928295cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_561f07dc-1fb1-4969-bfa0-b888e5a850c8" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_0afb6ea4-5a72-454f-9ee3-d75928295cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1c3fadb6-feef-48c6-ad86-e18a295be62f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_561f07dc-1fb1-4969-bfa0-b888e5a850c8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1c3fadb6-feef-48c6-ad86-e18a295be62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_32731f25-53ee-4485-877a-a87e6145a8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d887d480-50cf-4aa6-8e70-af60a67d083d" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_32731f25-53ee-4485-877a-a87e6145a8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_2c66a80b-2bad-4574-b452-fdc4af76d2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_32731f25-53ee-4485-877a-a87e6145a8c0" xlink:to="loc_us-gaap_InterestPaidNet_2c66a80b-2bad-4574-b452-fdc4af76d2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_44f4bcba-5f71-4fd2-9b77-276de8ad5595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d887d480-50cf-4aa6-8e70-af60a67d083d" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_44f4bcba-5f71-4fd2-9b77-276de8ad5595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1e2719ff-a88f-4bff-9fed-18721a13b56c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_44f4bcba-5f71-4fd2-9b77-276de8ad5595" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1e2719ff-a88f-4bff-9fed-18721a13b56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a487b0b1-f7e4-4fbc-86d2-c745ef933379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_44f4bcba-5f71-4fd2-9b77-276de8ad5595" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a487b0b1-f7e4-4fbc-86d2-c745ef933379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AggregateExercisePriceOfWarrantNetExercisedRelatedParty_29449a81-dcca-4667-8d70-b1cc9c745012" xlink:href="cccc-20221231.xsd#cccc_AggregateExercisePriceOfWarrantNetExercisedRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_44f4bcba-5f71-4fd2-9b77-276de8ad5595" xlink:to="loc_cccc_AggregateExercisePriceOfWarrantNetExercisedRelatedParty_29449a81-dcca-4667-8d70-b1cc9c745012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/ConsolidatedStatementsofCashFlowsParenthetical" xlink:type="simple" xlink:href="cccc-20221231.xsd#ConsolidatedStatementsofCashFlowsParenthetical"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/ConsolidatedStatementsofCashFlowsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5315deb5-cc82-45e6-a905-1245d1b1e294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_d4b57531-3073-4375-b5a0-af5e0bb05342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5315deb5-cc82-45e6-a905-1245d1b1e294" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_d4b57531-3073-4375-b5a0-af5e0bb05342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Natureofthebusiness" xlink:type="simple" xlink:href="cccc-20221231.xsd#Natureofthebusiness"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Natureofthebusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b08a24a6-89f5-4d95-8843-12a4d4000aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6a5aa19d-b160-49d5-8f24-33e0d8e5b26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b08a24a6-89f5-4d95-8843-12a4d4000aea" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6a5aa19d-b160-49d5-8f24-33e0d8e5b26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Summaryofsignificantaccountingpolicies" xlink:type="simple" xlink:href="cccc-20221231.xsd#Summaryofsignificantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Summaryofsignificantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c8ac1df7-6105-4fb2-9a7c-e50937b4f514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_9ed72e2b-c922-4860-b365-f3da74af166f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c8ac1df7-6105-4fb2-9a7c-e50937b4f514" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_9ed72e2b-c922-4860-b365-f3da74af166f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Fairvaluemeasurements" xlink:type="simple" xlink:href="cccc-20221231.xsd#Fairvaluemeasurements"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Fairvaluemeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_807f2e87-d97e-469d-843d-13d0042851fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_9edf8b73-d116-4ad1-899a-cceeebb39be5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_807f2e87-d97e-469d-843d-13d0042851fd" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_9edf8b73-d116-4ad1-899a-cceeebb39be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Marketablesecurities" xlink:type="simple" xlink:href="cccc-20221231.xsd#Marketablesecurities"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Marketablesecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_5451fd89-9485-4709-be1e-18bd4a7459cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_dcdb7612-f466-451c-bccf-f1e5e43a7d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_5451fd89-9485-4709-be1e-18bd4a7459cb" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_dcdb7612-f466-451c-bccf-f1e5e43a7d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Propertyandequipment" xlink:type="simple" xlink:href="cccc-20221231.xsd#Propertyandequipment"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Propertyandequipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2e3f06ed-959d-4883-afdf-7466da9195f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_ef884bf0-3557-4d44-8de6-0c481c3bd818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_2e3f06ed-959d-4883-afdf-7466da9195f9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_ef884bf0-3557-4d44-8de6-0c481c3bd818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Leases" xlink:type="simple" xlink:href="cccc-20221231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1cb767ce-0a83-4ece-bd35-4ffa043e6896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_4686671c-8b55-4fcb-a878-29030484a510" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1cb767ce-0a83-4ece-bd35-4ffa043e6896" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_4686671c-8b55-4fcb-a878-29030484a510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Accruedexpensesandothercurrentliabilities" xlink:type="simple" xlink:href="cccc-20221231.xsd#Accruedexpensesandothercurrentliabilities"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Accruedexpensesandothercurrentliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_d413fbf4-d0b7-4a61-8254-2bf4176fbd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_cd5aa472-1ec3-47be-a302-33c080ba538a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d413fbf4-d0b7-4a61-8254-2bf4176fbd0a" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_cd5aa472-1ec3-47be-a302-33c080ba538a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Collaborationandlicenseagreements" xlink:type="simple" xlink:href="cccc-20221231.xsd#Collaborationandlicenseagreements"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Collaborationandlicenseagreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_08b45d06-c4bd-49b0-8633-c254dca7515e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_e7859e8e-ade3-4ac2-81ce-96c36ec0529f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_08b45d06-c4bd-49b0-8633-c254dca7515e" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_e7859e8e-ade3-4ac2-81ce-96c36ec0529f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Longtermdebtandwarrantrelatedparty" xlink:type="simple" xlink:href="cccc-20221231.xsd#Longtermdebtandwarrantrelatedparty"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Longtermdebtandwarrantrelatedparty" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a43d3b33-ffaa-4661-9985-5d8c30d01b55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LongTermDebtAndWarrantRelatedPartyTextBlock_fe1d348a-7dce-4397-b726-c513f30bf635" xlink:href="cccc-20221231.xsd#cccc_LongTermDebtAndWarrantRelatedPartyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a43d3b33-ffaa-4661-9985-5d8c30d01b55" xlink:to="loc_cccc_LongTermDebtAndWarrantRelatedPartyTextBlock_fe1d348a-7dce-4397-b726-c513f30bf635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Stockholdersequity" xlink:type="simple" xlink:href="cccc-20221231.xsd#Stockholdersequity"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Stockholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_16cbf688-43cf-4d86-85e3-9c38b0f75864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6ee7e068-45d3-4c75-9932-28f95c283c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_16cbf688-43cf-4d86-85e3-9c38b0f75864" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6ee7e068-45d3-4c75-9932-28f95c283c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Stockbasedcompensation" xlink:type="simple" xlink:href="cccc-20221231.xsd#Stockbasedcompensation"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Stockbasedcompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dcb5dcee-555f-4a89-a853-69364acfcfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_bb796074-8410-4234-b5a6-a9f705e11a86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dcb5dcee-555f-4a89-a853-69364acfcfdd" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_bb796074-8410-4234-b5a6-a9f705e11a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cccc-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7d8fc377-b0a1-4c95-b1f5-caddcf1ade92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_898a5650-8a6b-432f-919b-f37d30855502" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7d8fc377-b0a1-4c95-b1f5-caddcf1ade92" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_898a5650-8a6b-432f-919b-f37d30855502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/NetLosspershare" xlink:type="simple" xlink:href="cccc-20221231.xsd#NetLosspershare"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/NetLosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a3727682-e69a-4706-8c98-8b27b69bdd44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_3be08a6f-e39a-4624-903f-340b0618a16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a3727682-e69a-4706-8c98-8b27b69bdd44" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_3be08a6f-e39a-4624-903f-340b0618a16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/Definedcontributionplan" xlink:type="simple" xlink:href="cccc-20221231.xsd#Definedcontributionplan"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/Definedcontributionplan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b67b0fa9-573b-40b7-8674-79adbe82c1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTextBlock_4feb5a3b-7be0-42d0-ba3d-1647c2ad3787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b67b0fa9-573b-40b7-8674-79adbe82c1dc" xlink:to="loc_us-gaap_DefinedContributionPlanTextBlock_4feb5a3b-7be0-42d0-ba3d-1647c2ad3787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="cccc-20221231.xsd#SummaryofsignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ddf3b381-4318-44d2-90fb-b45ae6e49aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ddf3b381-4318-44d2-90fb-b45ae6e49aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_95f2a91e-b9c0-47b3-b479-d43376b6716e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_95f2a91e-b9c0-47b3-b479-d43376b6716e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_0f37105e-704e-42aa-8b0d-bc1524b4a3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_UseOfEstimates_0f37105e-704e-42aa-8b0d-bc1524b4a3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_00fde2a7-dcb6-40f5-ba35-261e2b2f3dba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_00fde2a7-dcb6-40f5-ba35-261e2b2f3dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_feaec24a-161f-45a1-ba38-70fff615e7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_feaec24a-161f-45a1-ba38-70fff615e7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_0b360a7b-cb47-48dc-b128-5b05aaefc7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_0b360a7b-cb47-48dc-b128-5b05aaefc7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_d0e6e7d7-d23b-46f2-8eea-3eeaa0430039" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_d0e6e7d7-d23b-46f2-8eea-3eeaa0430039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_8e99e087-cca0-4442-b827-b30833f82c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_8e99e087-cca0-4442-b827-b30833f82c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_7336fc81-9f6e-48cb-be16-c36f6f54db90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_7336fc81-9f6e-48cb-be16-c36f6f54db90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d4de5920-1aae-4483-9127-db8c94b0170a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d4de5920-1aae-4483-9127-db8c94b0170a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_bef5f9b5-a068-4ff4-b980-1986ae37fcfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_bef5f9b5-a068-4ff4-b980-1986ae37fcfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_8a7fa05c-eb0a-4c0d-a872-0da0c4b2a58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_8a7fa05c-eb0a-4c0d-a872-0da0c4b2a58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_37c684a9-b2e9-42f9-b97a-642bf293ac0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_37c684a9-b2e9-42f9-b97a-642bf293ac0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_41729842-0b4f-459d-b63d-2389b1fd256b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_41729842-0b4f-459d-b63d-2389b1fd256b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_dfe31945-f192-4020-9a43-d7677cf18386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_dfe31945-f192-4020-9a43-d7677cf18386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_9fd9d9ca-b9db-489e-8269-743f736509f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_9fd9d9ca-b9db-489e-8269-743f736509f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_ec7c2290-9a13-4852-8e9f-eef6c8b7bd12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_ec7c2290-9a13-4852-8e9f-eef6c8b7bd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_962443ca-ff6c-4345-9877-81b056f5b661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_962443ca-ff6c-4345-9877-81b056f5b661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_7751a7c3-c3e6-43d7-979b-75cee50fae3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_7751a7c3-c3e6-43d7-979b-75cee50fae3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_GoingConcernPolicyPolicyTextBlock_5110eb6e-1137-48c5-ac51-d0719be7bbc7" xlink:href="cccc-20221231.xsd#cccc_GoingConcernPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_cccc_GoingConcernPolicyPolicyTextBlock_5110eb6e-1137-48c5-ac51-d0719be7bbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_be63af34-8317-4127-82c6-0983be6eb553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ef43546-9173-40b9-9a0d-b76ff3fc3e15" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_be63af34-8317-4127-82c6-0983be6eb553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#SummaryofsignificantaccountingpoliciesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_21c1dbfe-83eb-4fc2-837d-609532df2c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6f5ffe5a-6a5d-44c7-bbd4-1a5e0d6eb7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21c1dbfe-83eb-4fc2-837d-609532df2c4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6f5ffe5a-6a5d-44c7-bbd4-1a5e0d6eb7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/FairvaluemeasurementsTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#FairvaluemeasurementsTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/FairvaluemeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_94dd4efc-0759-4202-9bab-f9c5c173eb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_a1ee0578-129e-4591-a2c2-ed92282b74d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_94dd4efc-0759-4202-9bab-f9c5c173eb4c" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_a1ee0578-129e-4591-a2c2-ed92282b74d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#MarketablesecuritiesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_d409eaa3-3652-4fa0-b77d-436a93eed339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_c4c94850-51af-4217-a23c-2d9574e196a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_d409eaa3-3652-4fa0-b77d-436a93eed339" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_c4c94850-51af-4217-a23c-2d9574e196a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_74d31682-482c-4d77-b7a8-167b3b385187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_d409eaa3-3652-4fa0-b77d-436a93eed339" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_74d31682-482c-4d77-b7a8-167b3b385187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/PropertyandequipmentTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#PropertyandequipmentTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/PropertyandequipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_eb7f55c2-711d-468c-ae58-91d9aa85f917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_640de510-0d80-484b-af43-3a26ab32411f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_eb7f55c2-711d-468c-ae58-91d9aa85f917" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_640de510-0d80-484b-af43-3a26ab32411f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ScheduleOfDepreciationExpenseTableTableTextBlock_9dda606c-55ed-4943-b0bf-7af29464cb00" xlink:href="cccc-20221231.xsd#cccc_ScheduleOfDepreciationExpenseTableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_eb7f55c2-711d-468c-ae58-91d9aa85f917" xlink:to="loc_cccc_ScheduleOfDepreciationExpenseTableTableTextBlock_9dda606c-55ed-4943-b0bf-7af29464cb00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f5364b92-0d9a-48f0-afec-b3ce7c6a66b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_d14a4029-5063-43cb-9daf-5580183dd26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f5364b92-0d9a-48f0-afec-b3ce7c6a66b3" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_d14a4029-5063-43cb-9daf-5580183dd26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_SummaryOfLeaseTermAndIncrementalBorrowingRateAppliedInArrivingAtLeaseLiabilityTableTableTextBlock_593e7fa5-9519-45fc-aaa1-83dd29937bb0" xlink:href="cccc-20221231.xsd#cccc_SummaryOfLeaseTermAndIncrementalBorrowingRateAppliedInArrivingAtLeaseLiabilityTableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f5364b92-0d9a-48f0-afec-b3ce7c6a66b3" xlink:to="loc_cccc_SummaryOfLeaseTermAndIncrementalBorrowingRateAppliedInArrivingAtLeaseLiabilityTableTableTextBlock_593e7fa5-9519-45fc-aaa1-83dd29937bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_39b3e49e-8bda-4ccb-9bac-8b81bb95b92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f5364b92-0d9a-48f0-afec-b3ce7c6a66b3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_39b3e49e-8bda-4ccb-9bac-8b81bb95b92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#AccruedexpensesandothercurrentliabilitiesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_1a6d3505-c758-4008-b797-04a1ca7fbb46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3f253117-f4c9-499f-8b48-43a214739500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_1a6d3505-c758-4008-b797-04a1ca7fbb46" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_3f253117-f4c9-499f-8b48-43a214739500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#CollaborationandlicenseagreementsTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_715a0c2e-8448-4dc0-bce1-2ee55d03bf6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_SummaryOfAllocationOfTotalTransactionPriceAndUnsatisfiedTransactionPriceTableTableTextBlock_d4ee99f9-60c0-47d4-805a-cfc9efbfbf34" xlink:href="cccc-20221231.xsd#cccc_SummaryOfAllocationOfTotalTransactionPriceAndUnsatisfiedTransactionPriceTableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_715a0c2e-8448-4dc0-bce1-2ee55d03bf6b" xlink:to="loc_cccc_SummaryOfAllocationOfTotalTransactionPriceAndUnsatisfiedTransactionPriceTableTableTextBlock_d4ee99f9-60c0-47d4-805a-cfc9efbfbf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RevenueFromCollaborationAgreementsTableTableTextBlock_de85822e-e10a-464a-b447-e14517ead341" xlink:href="cccc-20221231.xsd#cccc_RevenueFromCollaborationAgreementsTableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_715a0c2e-8448-4dc0-bce1-2ee55d03bf6b" xlink:to="loc_cccc_RevenueFromCollaborationAgreementsTableTableTextBlock_de85822e-e10a-464a-b447-e14517ead341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_FinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_ac21bf91-92c4-4fda-b3ad-e6dbf893d4a8" xlink:href="cccc-20221231.xsd#cccc_FinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_715a0c2e-8448-4dc0-bce1-2ee55d03bf6b" xlink:to="loc_cccc_FinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_ac21bf91-92c4-4fda-b3ad-e6dbf893d4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_SupplementalFinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_16b28e72-6154-478f-875a-b50e5b8a73fd" xlink:href="cccc-20221231.xsd#cccc_SupplementalFinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_715a0c2e-8448-4dc0-bce1-2ee55d03bf6b" xlink:to="loc_cccc_SupplementalFinancialInformationRelatedToCollaborationAndLicenseAgreementsTableTableTextBlock_16b28e72-6154-478f-875a-b50e5b8a73fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#LongtermdebtandwarrantrelatedpartyTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_95859c99-93c3-46b1-9825-3a3f30b3b5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_12c682c6-f998-497e-9876-d27527b84cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95859c99-93c3-46b1-9825-3a3f30b3b5c8" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_12c682c6-f998-497e-9876-d27527b84cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#StockbasedcompensationTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2dd1bbd8-954a-4c33-b6ff-089566eb3287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_02dae8d5-490f-464c-a68e-fa696909a187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2dd1bbd8-954a-4c33-b6ff-089566eb3287" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_02dae8d5-490f-464c-a68e-fa696909a187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e4c7ee04-e211-43c7-85a1-711e7894dd52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2dd1bbd8-954a-4c33-b6ff-089566eb3287" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e4c7ee04-e211-43c7-85a1-711e7894dd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c10253c5-71f0-4bfb-aeba-e04691474d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2dd1bbd8-954a-4c33-b6ff-089566eb3287" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c10253c5-71f0-4bfb-aeba-e04691474d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_9cbb6ecc-6c7c-44b9-8dd7-069d9f62e29e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2dd1bbd8-954a-4c33-b6ff-089566eb3287" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_9cbb6ecc-6c7c-44b9-8dd7-069d9f62e29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4c5c2387-df09-4f6c-b35d-b66940b50796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_bc6be378-c7fb-4b3e-9641-990bd2ab51a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4c5c2387-df09-4f6c-b35d-b66940b50796" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_bc6be378-c7fb-4b3e-9641-990bd2ab51a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a8e36c85-11fa-47d6-a982-cd071425a935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4c5c2387-df09-4f6c-b35d-b66940b50796" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_a8e36c85-11fa-47d6-a982-cd071425a935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c25f3c8c-235f-4ead-9d99-70b9df31a895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4c5c2387-df09-4f6c-b35d-b66940b50796" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c25f3c8c-235f-4ead-9d99-70b9df31a895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/NetLosspershareTables" xlink:type="simple" xlink:href="cccc-20221231.xsd#NetLosspershareTables"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/NetLosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_04b322cb-50b1-45d7-b667-bc658671b4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_64416a80-98e6-4e96-a502-64715284cf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_04b322cb-50b1-45d7-b667-bc658671b4ae" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_64416a80-98e6-4e96-a502-64715284cf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9eb4c5da-9a4b-4190-8b95-452b60e84017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_04b322cb-50b1-45d7-b667-bc658671b4ae" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9eb4c5da-9a4b-4190-8b95-452b60e84017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/NatureofthebusinessDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#NatureofthebusinessDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/NatureofthebusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87b45daa-d625-4fdd-9a36-1b1b9b5a2336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d2601729-32bf-4e82-81cc-a46b83f16ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87b45daa-d625-4fdd-9a36-1b1b9b5a2336" xlink:to="loc_us-gaap_NetIncomeLoss_d2601729-32bf-4e82-81cc-a46b83f16ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1d23e4fd-0ddf-4869-8e14-2f35976b7c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87b45daa-d625-4fdd-9a36-1b1b9b5a2336" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1d23e4fd-0ddf-4869-8e14-2f35976b7c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_44ab9dd5-be70-442c-81e3-83ce27a99838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87b45daa-d625-4fdd-9a36-1b1b9b5a2336" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_44ab9dd5-be70-442c-81e3-83ce27a99838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#SummaryofsignificantaccountingpoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_beb5acc6-9061-487a-b8fb-4001ea7f1c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_ab7ca4eb-334f-48dd-8c67-19a5479ebb03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_beb5acc6-9061-487a-b8fb-4001ea7f1c76" xlink:to="loc_us-gaap_NumberOfOperatingSegments_ab7ca4eb-334f-48dd-8c67-19a5479ebb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_c2c5815c-a9ec-4fd0-a3eb-2d3190bee1df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_beb5acc6-9061-487a-b8fb-4001ea7f1c76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments_c2c5815c-a9ec-4fd0-a3eb-2d3190bee1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesSummaryofpropertyandequipmentusefullivesDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#SummaryofsignificantaccountingpoliciesSummaryofpropertyandequipmentusefullivesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/SummaryofsignificantaccountingpoliciesSummaryofpropertyandequipmentusefullivesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fa024a4c-5ddc-4e52-9df0-b1c52a2dc347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5a36e93a-2391-40ee-adb7-ffa2731be7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fa024a4c-5ddc-4e52-9df0-b1c52a2dc347" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5a36e93a-2391-40ee-adb7-ffa2731be7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_193e3264-2ddf-40fb-9d23-32e62ce1b812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5a36e93a-2391-40ee-adb7-ffa2731be7b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_193e3264-2ddf-40fb-9d23-32e62ce1b812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d3957de-b37d-49a3-93c6-092b5824c7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_193e3264-2ddf-40fb-9d23-32e62ce1b812" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d3957de-b37d-49a3-93c6-092b5824c7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LaboratoryEquipmentMember_0580fb57-6c4e-40e5-962a-9dbf7a68c8be" xlink:href="cccc-20221231.xsd#cccc_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d3957de-b37d-49a3-93c6-092b5824c7a9" xlink:to="loc_cccc_LaboratoryEquipmentMember_0580fb57-6c4e-40e5-962a-9dbf7a68c8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_62299c54-cdf3-43c0-a193-ea6eef075b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d3957de-b37d-49a3-93c6-092b5824c7a9" xlink:to="loc_us-gaap_ComputerEquipmentMember_62299c54-cdf3-43c0-a193-ea6eef075b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OfficeEquipmentFurnitureAndFixturesMember_dc0dfd7b-6d1b-45d9-989c-89027c0ba5a2" xlink:href="cccc-20221231.xsd#cccc_OfficeEquipmentFurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d3957de-b37d-49a3-93c6-092b5824c7a9" xlink:to="loc_cccc_OfficeEquipmentFurnitureAndFixturesMember_dc0dfd7b-6d1b-45d9-989c-89027c0ba5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_608a3966-c67e-4293-89aa-8da32295e17a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8d3957de-b37d-49a3-93c6-092b5824c7a9" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_608a3966-c67e-4293-89aa-8da32295e17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbfc8825-818c-4bb4-9a7d-6e17ca6b2dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5a36e93a-2391-40ee-adb7-ffa2731be7b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbfc8825-818c-4bb4-9a7d-6e17ca6b2dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8af4db0c-e635-4df7-845b-ee175aa4537a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbfc8825-818c-4bb4-9a7d-6e17ca6b2dbb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8af4db0c-e635-4df7-845b-ee175aa4537a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_81c236ad-ca41-465d-b66a-e460055fab3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bbfc8825-818c-4bb4-9a7d-6e17ca6b2dbb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_81c236ad-ca41-465d-b66a-e460055fab3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/FairvaluemeasurementsDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#FairvaluemeasurementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/FairvaluemeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a3c5699b-efcc-42bf-bf17-608c3c7d587d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8e97fd63-b3ce-4cd1-ae9b-0420d859bdc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a3c5699b-efcc-42bf-bf17-608c3c7d587d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8e97fd63-b3ce-4cd1-ae9b-0420d859bdc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_806ca95d-4133-467a-84ef-3c978f6fc43a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8e97fd63-b3ce-4cd1-ae9b-0420d859bdc4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_806ca95d-4133-467a-84ef-3c978f6fc43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f57c8bb1-b272-4fad-a118-e95a5995e7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_806ca95d-4133-467a-84ef-3c978f6fc43a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f57c8bb1-b272-4fad-a118-e95a5995e7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_07e5da94-4243-426c-85f6-edd74cf0c5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f57c8bb1-b272-4fad-a118-e95a5995e7ae" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_07e5da94-4243-426c-85f6-edd74cf0c5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c632d21d-6201-49ed-9e48-c2890b09553d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f57c8bb1-b272-4fad-a118-e95a5995e7ae" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c632d21d-6201-49ed-9e48-c2890b09553d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_839c027a-44bc-48ca-90f6-aaae7ea4af30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f57c8bb1-b272-4fad-a118-e95a5995e7ae" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_839c027a-44bc-48ca-90f6-aaae7ea4af30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_00886c61-17af-463a-b57d-71e5d37d4ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8e97fd63-b3ce-4cd1-ae9b-0420d859bdc4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_00886c61-17af-463a-b57d-71e5d37d4ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_04369a78-f2e1-42e8-b937-0d1107ff4bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_00886c61-17af-463a-b57d-71e5d37d4ec7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_04369a78-f2e1-42e8-b937-0d1107ff4bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_18d7dc26-f273-4404-8796-25dffcab3c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_04369a78-f2e1-42e8-b937-0d1107ff4bcb" xlink:to="loc_us-gaap_MoneyMarketFundsMember_18d7dc26-f273-4404-8796-25dffcab3c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_be3494a1-11bd-42ca-92a9-ce04509f1037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_04369a78-f2e1-42e8-b937-0d1107ff4bcb" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_be3494a1-11bd-42ca-92a9-ce04509f1037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_d4dbd34b-1a8d-4153-aa27-db6e9a2591a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_04369a78-f2e1-42e8-b937-0d1107ff4bcb" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_d4dbd34b-1a8d-4153-aa27-db6e9a2591a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_84a52c4b-30e5-499f-b002-727307a0a92f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8e97fd63-b3ce-4cd1-ae9b-0420d859bdc4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_84a52c4b-30e5-499f-b002-727307a0a92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc303c84-2bbc-4f55-b2e9-bf4c35725c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_84a52c4b-30e5-499f-b002-727307a0a92f" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc303c84-2bbc-4f55-b2e9-bf4c35725c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_17019391-ad77-4d5b-89f7-ab0d6e1cf870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc303c84-2bbc-4f55-b2e9-bf4c35725c82" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_17019391-ad77-4d5b-89f7-ab0d6e1cf870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_0d198d01-a7cc-4e4f-b16e-0c3b14550ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc303c84-2bbc-4f55-b2e9-bf4c35725c82" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_0d198d01-a7cc-4e4f-b16e-0c3b14550ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_6f1835c0-a6cb-4d4f-a16d-257399f936e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bc303c84-2bbc-4f55-b2e9-bf4c35725c82" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_6f1835c0-a6cb-4d4f-a16d-257399f936e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f51f32ae-a5f2-44ec-9f6b-5c6d792e4f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8e97fd63-b3ce-4cd1-ae9b-0420d859bdc4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f51f32ae-a5f2-44ec-9f6b-5c6d792e4f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_39125946-07cd-46d8-80dd-d3550ff9dbd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f51f32ae-a5f2-44ec-9f6b-5c6d792e4f98" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_39125946-07cd-46d8-80dd-d3550ff9dbd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_94765c95-6f75-434b-8602-8cc23fd71b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f51f32ae-a5f2-44ec-9f6b-5c6d792e4f98" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_94765c95-6f75-434b-8602-8cc23fd71b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ba92654c-6b16-47a8-9d29-dbfb8937495f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f51f32ae-a5f2-44ec-9f6b-5c6d792e4f98" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_ba92654c-6b16-47a8-9d29-dbfb8937495f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#MarketablesecuritiesSummaryofmarketablesecuritiesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_a77e85ae-d362-445c-a638-c43e495e100f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_43feb589-8572-428b-b2f5-df8e063aece2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_a77e85ae-d362-445c-a638-c43e495e100f" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_43feb589-8572-428b-b2f5-df8e063aece2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f33da600-0ce1-43e0-b7d5-897f9d037214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_43feb589-8572-428b-b2f5-df8e063aece2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f33da600-0ce1-43e0-b7d5-897f9d037214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f054bb1b-62b8-4d5b-825f-1597d5359b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f33da600-0ce1-43e0-b7d5-897f9d037214" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f054bb1b-62b8-4d5b-825f-1597d5359b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_4c4f8370-f77c-4c6b-960d-5e25eb79860a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f054bb1b-62b8-4d5b-825f-1597d5359b4c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_4c4f8370-f77c-4c6b-960d-5e25eb79860a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_be8b3d63-d87f-482b-b2c6-a0bd72833ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f054bb1b-62b8-4d5b-825f-1597d5359b4c" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_be8b3d63-d87f-482b-b2c6-a0bd72833ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_a72135f9-16e6-4dff-9e26-36901daaa6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f054bb1b-62b8-4d5b-825f-1597d5359b4c" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_a72135f9-16e6-4dff-9e26-36901daaa6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4ef427ab-28d7-4fb3-9385-8d73e6b1bd34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_43feb589-8572-428b-b2f5-df8e063aece2" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4ef427ab-28d7-4fb3-9385-8d73e6b1bd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_b5981d59-7719-4d2a-9f53-f97da6d644c0" xlink:href="cccc-20221231.xsd#cccc_DebtSecuritiesAvailableForSaleCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4ef427ab-28d7-4fb3-9385-8d73e6b1bd34" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_b5981d59-7719-4d2a-9f53-f97da6d644c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_807f96ae-1cf3-4626-b3fe-57219b95ed34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_b5981d59-7719-4d2a-9f53-f97da6d644c0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossCurrent_807f96ae-1cf3-4626-b3fe-57219b95ed34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_096b1827-1ce8-4e17-bebf-9db7ba205d50" xlink:href="cccc-20221231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_b5981d59-7719-4d2a-9f53-f97da6d644c0" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxCurrent_096b1827-1ce8-4e17-bebf-9db7ba205d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_471375be-deb6-4bcf-a1e8-322bb1aa3d36" xlink:href="cccc-20221231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_b5981d59-7719-4d2a-9f53-f97da6d644c0" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent_471375be-deb6-4bcf-a1e8-322bb1aa3d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_ea40e3e8-133c-4f1e-9b59-c2ac5d660d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleCurrentAbstract_b5981d59-7719-4d2a-9f53-f97da6d644c0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_ea40e3e8-133c-4f1e-9b59-c2ac5d660d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_3b2a182a-1192-4910-9c54-c44eb9163d8a" xlink:href="cccc-20221231.xsd#cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4ef427ab-28d7-4fb3-9385-8d73e6b1bd34" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_3b2a182a-1192-4910-9c54-c44eb9163d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_6b1560fc-fa8e-4d60-af32-aa8cf8f885ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_3b2a182a-1192-4910-9c54-c44eb9163d8a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent_6b1560fc-fa8e-4d60-af32-aa8cf8f885ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent_8931f2ee-3be0-4a54-98b1-fbd1781f0c3f" xlink:href="cccc-20221231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_3b2a182a-1192-4910-9c54-c44eb9163d8a" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTaxNoncurrent_8931f2ee-3be0-4a54-98b1-fbd1781f0c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent_ffe1817b-f289-4df1-801f-d4a7191a19da" xlink:href="cccc-20221231.xsd#cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_3b2a182a-1192-4910-9c54-c44eb9163d8a" xlink:to="loc_cccc_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxNoncurrent_ffe1817b-f289-4df1-801f-d4a7191a19da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_8e67da50-9439-4287-929f-bf5b0b9e8cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_DebtSecuritiesAvailableForSaleNoncurrentAbstract_3b2a182a-1192-4910-9c54-c44eb9163d8a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent_8e67da50-9439-4287-929f-bf5b0b9e8cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_8c2ecfd3-b905-4f90-90a8-4c0aa5c8d3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4ef427ab-28d7-4fb3-9385-8d73e6b1bd34" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_8c2ecfd3-b905-4f90-90a8-4c0aa5c8d3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_41888a21-d631-4f8d-b3f5-0131e0acb40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4ef427ab-28d7-4fb3-9385-8d73e6b1bd34" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_41888a21-d631-4f8d-b3f5-0131e0acb40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9dbdcdcc-86d3-41df-85a8-6b475baddf22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4ef427ab-28d7-4fb3-9385-8d73e6b1bd34" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9dbdcdcc-86d3-41df-85a8-6b475baddf22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_58e78ff1-7f11-4851-be50-968ccdff07a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_4ef427ab-28d7-4fb3-9385-8d73e6b1bd34" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_58e78ff1-7f11-4851-be50-968ccdff07a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails_1" xlink:type="simple" xlink:href="cccc-20221231.xsd#MarketablesecuritiesSummaryofmarketablesecuritiesDetails_1"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesinunrealizedlosspositionDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#MarketablesecuritiesSummaryofmarketablesecuritiesinunrealizedlosspositionDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesSummaryofmarketablesecuritiesinunrealizedlosspositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_d9e92f9b-39c1-40ca-8ac0-a42f2ddb234e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3a83992c-e545-422d-80d1-9b9823ec7a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_d9e92f9b-39c1-40ca-8ac0-a42f2ddb234e" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3a83992c-e545-422d-80d1-9b9823ec7a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_e485cde4-dfb3-4921-853c-baffd3815868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3a83992c-e545-422d-80d1-9b9823ec7a4c" xlink:to="loc_us-gaap_InvestmentTypeAxis_e485cde4-dfb3-4921-853c-baffd3815868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_7f7f4d16-39ea-4a95-b083-e2c0fa053ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_e485cde4-dfb3-4921-853c-baffd3815868" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_7f7f4d16-39ea-4a95-b083-e2c0fa053ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_191b0b01-3659-4cd6-aefc-242ba7d1a395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7f7f4d16-39ea-4a95-b083-e2c0fa053ad8" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_191b0b01-3659-4cd6-aefc-242ba7d1a395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_718dbcd8-d344-4fa0-92d5-8cf884f86295" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7f7f4d16-39ea-4a95-b083-e2c0fa053ad8" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_718dbcd8-d344-4fa0-92d5-8cf884f86295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_7f4ff5fb-a359-4194-bf93-157ee99c43d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_7f7f4d16-39ea-4a95-b083-e2c0fa053ad8" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_7f4ff5fb-a359-4194-bf93-157ee99c43d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a3d30faa-8b19-415d-9fbe-b4cfa267998c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_3a83992c-e545-422d-80d1-9b9823ec7a4c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a3d30faa-8b19-415d-9fbe-b4cfa267998c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_010b14ae-f5e4-4d12-b9b4-3c58ba069d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a3d30faa-8b19-415d-9fbe-b4cfa267998c" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_010b14ae-f5e4-4d12-b9b4-3c58ba069d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_ca5a375a-71e7-4389-b769-0ae5e7979316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_010b14ae-f5e4-4d12-b9b4-3c58ba069d20" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_ca5a375a-71e7-4389-b769-0ae5e7979316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_955344c5-2e36-4560-9856-cb90d912e656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_010b14ae-f5e4-4d12-b9b4-3c58ba069d20" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_955344c5-2e36-4560-9856-cb90d912e656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_d01ed1de-de41-4dc5-b361-3a367a3f0cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_010b14ae-f5e4-4d12-b9b4-3c58ba069d20" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_d01ed1de-de41-4dc5-b361-3a367a3f0cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_ac84794c-e0bf-4739-9e23-7bf13a77e5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a3d30faa-8b19-415d-9fbe-b4cfa267998c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_ac84794c-e0bf-4739-9e23-7bf13a77e5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_9d286d07-92a6-48d5-a801-426b059d0176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_ac84794c-e0bf-4739-9e23-7bf13a77e5f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_9d286d07-92a6-48d5-a801-426b059d0176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_8d08987e-94f2-498e-a835-93c0d1b685cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_ac84794c-e0bf-4739-9e23-7bf13a77e5f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_8d08987e-94f2-498e-a835-93c0d1b685cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_b7b92349-4618-42b1-971e-9116315c594b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforSaleUnrealizedLossPositionAbstract_ac84794c-e0bf-4739-9e23-7bf13a77e5f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_b7b92349-4618-42b1-971e-9116315c594b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd381a36-a316-4ff4-81c1-8cda8a780e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_a3d30faa-8b19-415d-9fbe-b4cfa267998c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd381a36-a316-4ff4-81c1-8cda8a780e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_163c68b8-bac0-418e-a541-0bccdd13f9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd381a36-a316-4ff4-81c1-8cda8a780e96" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_163c68b8-bac0-418e-a541-0bccdd13f9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_be8c6d94-5a28-4c14-b7ff-99ffaf395c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd381a36-a316-4ff4-81c1-8cda8a780e96" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_be8c6d94-5a28-4c14-b7ff-99ffaf395c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3f0e3285-6a7c-43bc-bff2-28499668b4fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_bd381a36-a316-4ff4-81c1-8cda8a780e96" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3f0e3285-6a7c-43bc-bff2-28499668b4fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/MarketablesecuritiesNarrativeDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#MarketablesecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/MarketablesecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesAbstract_7cf6ec39-8a4c-4e93-a826-e0cd02468835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0a6b48c7-13d2-42ac-8e90-dbc109caf8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_7cf6ec39-8a4c-4e93-a826-e0cd02468835" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0a6b48c7-13d2-42ac-8e90-dbc109caf8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_0c84a837-7cb5-4b0c-88bf-1e0457165d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesAbstract_7cf6ec39-8a4c-4e93-a826-e0cd02468835" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest_0c84a837-7cb5-4b0c-88bf-1e0457165d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/PropertyandequipmentSummaryofpropertyandequipmentDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#PropertyandequipmentSummaryofpropertyandequipmentDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/PropertyandequipmentSummaryofpropertyandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_43baa830-d24f-4b22-8fdb-97efa78f55ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d870265-85e7-4845-8be6-a15b05503c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_43baa830-d24f-4b22-8fdb-97efa78f55ff" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d870265-85e7-4845-8be6-a15b05503c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_05e1a965-c04d-463b-9ec6-99621ac16ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d870265-85e7-4845-8be6-a15b05503c24" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_05e1a965-c04d-463b-9ec6-99621ac16ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f445b2d0-517a-428c-a3a5-de4174cf0413" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_05e1a965-c04d-463b-9ec6-99621ac16ef7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f445b2d0-517a-428c-a3a5-de4174cf0413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LaboratoryEquipmentMember_3921ff8a-f3d4-4c14-9051-b0119fd2dd69" xlink:href="cccc-20221231.xsd#cccc_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f445b2d0-517a-428c-a3a5-de4174cf0413" xlink:to="loc_cccc_LaboratoryEquipmentMember_3921ff8a-f3d4-4c14-9051-b0119fd2dd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_57c365fb-011c-4a3a-91ea-20e27de536c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdsAndLeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f445b2d0-517a-428c-a3a5-de4174cf0413" xlink:to="loc_us-gaap_LeaseholdsAndLeaseholdImprovementsMember_57c365fb-011c-4a3a-91ea-20e27de536c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_6511b048-cbed-44dc-abb7-91241834e34a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f445b2d0-517a-428c-a3a5-de4174cf0413" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_6511b048-cbed-44dc-abb7-91241834e34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_388a5c29-f161-49fc-81f0-22e83d27ef9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f445b2d0-517a-428c-a3a5-de4174cf0413" xlink:to="loc_us-gaap_OfficeEquipmentMember_388a5c29-f161-49fc-81f0-22e83d27ef9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_4d8637ee-52df-49fc-9308-4baacca5a4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f445b2d0-517a-428c-a3a5-de4174cf0413" xlink:to="loc_us-gaap_ComputerEquipmentMember_4d8637ee-52df-49fc-9308-4baacca5a4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_4917b62a-d48b-4551-ac18-bffff834521e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f445b2d0-517a-428c-a3a5-de4174cf0413" xlink:to="loc_us-gaap_ConstructionInProgressMember_4917b62a-d48b-4551-ac18-bffff834521e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7c48d8f4-c7b1-4007-b360-22db2dd30484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_2d870265-85e7-4845-8be6-a15b05503c24" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7c48d8f4-c7b1-4007-b360-22db2dd30484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1e064699-b111-4ac4-a113-fcc7a5da699f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7c48d8f4-c7b1-4007-b360-22db2dd30484" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1e064699-b111-4ac4-a113-fcc7a5da699f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f085a6fe-29bf-410e-8ed6-6df93a854115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7c48d8f4-c7b1-4007-b360-22db2dd30484" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f085a6fe-29bf-410e-8ed6-6df93a854115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b9623815-5fce-4ee1-aa45-fbc76ff4e294" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7c48d8f4-c7b1-4007-b360-22db2dd30484" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b9623815-5fce-4ee1-aa45-fbc76ff4e294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/PropertyandequipmentSummaryofdepreciationexpenseDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#PropertyandequipmentSummaryofdepreciationexpenseDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/PropertyandequipmentSummaryofdepreciationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_bed1f8c2-fa6b-48ef-82f3-d7d030960dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_135218aa-ee5f-40af-80b4-65efd845e333" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_bed1f8c2-fa6b-48ef-82f3-d7d030960dc6" xlink:to="loc_us-gaap_Depreciation_135218aa-ee5f-40af-80b4-65efd845e333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_69288bb4-d6e2-4968-86de-2fdf3b57523f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_b0db26b0-a1de-48d5-bf9d-3a9eb1ef9d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_69288bb4-d6e2-4968-86de-2fdf3b57523f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_b0db26b0-a1de-48d5-bf9d-3a9eb1ef9d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_ef58acb0-f012-4756-9ed1-4f1d7dd34d47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b0db26b0-a1de-48d5-bf9d-3a9eb1ef9d5e" xlink:to="loc_us-gaap_LeaseContractualTermAxis_ef58acb0-f012-4756-9ed1-4f1d7dd34d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_9f646d26-fcf1-463b-9e36-68239a846735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_ef58acb0-f012-4756-9ed1-4f1d7dd34d47" xlink:to="loc_us-gaap_LeaseContractualTermDomain_9f646d26-fcf1-463b-9e36-68239a846735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_WatertownLeaseMember_0a7d8ee8-138c-4d8c-b35b-6f7f740c5b62" xlink:href="cccc-20221231.xsd#cccc_WatertownLeaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_9f646d26-fcf1-463b-9e36-68239a846735" xlink:to="loc_cccc_WatertownLeaseMember_0a7d8ee8-138c-4d8c-b35b-6f7f740c5b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b440a53a-843d-44f3-9953-d7856373090e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b0db26b0-a1de-48d5-bf9d-3a9eb1ef9d5e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b440a53a-843d-44f3-9953-d7856373090e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ea5fece5-1d9e-46bc-af21-59dfff054f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b440a53a-843d-44f3-9953-d7856373090e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ea5fece5-1d9e-46bc-af21-59dfff054f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OfficeAndLaboratorySpaceMember_f148a098-bbd5-44f6-9a27-baee7f83b516" xlink:href="cccc-20221231.xsd#cccc_OfficeAndLaboratorySpaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ea5fece5-1d9e-46bc-af21-59dfff054f7b" xlink:to="loc_cccc_OfficeAndLaboratorySpaceMember_f148a098-bbd5-44f6-9a27-baee7f83b516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NewlyLeasedSpaceMember_5566ce1e-04d2-4f30-ac06-e813cb001ade" xlink:href="cccc-20221231.xsd#cccc_NewlyLeasedSpaceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ea5fece5-1d9e-46bc-af21-59dfff054f7b" xlink:to="loc_cccc_NewlyLeasedSpaceMember_5566ce1e-04d2-4f30-ac06-e813cb001ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_b0db26b0-a1de-48d5-bf9d-3a9eb1ef9d5e" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_edfd4c8b-35a2-4d43-8341-ca1ab9f2bc00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_edfd4c8b-35a2-4d43-8341-ca1ab9f2bc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LesseeOperatingLeaseNumberOfRenewalOptions_2c5a6c1f-247a-402f-8365-dfe55926bcfc" xlink:href="cccc-20221231.xsd#cccc_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:to="loc_cccc_LesseeOperatingLeaseNumberOfRenewalOptions_2c5a6c1f-247a-402f-8365-dfe55926bcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9a538bec-44f4-490c-b22d-83e230eefbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_9a538bec-44f4-490c-b22d-83e230eefbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_951099b4-de40-42a0-8e02-1b6574d521a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:to="loc_us-gaap_OperatingLeaseLiability_951099b4-de40-42a0-8e02-1b6574d521a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4f00f1d1-5d3d-4ea5-83c1-6eb7cd75c9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4f00f1d1-5d3d-4ea5-83c1-6eb7cd75c9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionPayableCurrent_e45ee4dd-ec01-4b65-b4b1-40d44260fc82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:to="loc_us-gaap_ConstructionPayableCurrent_e45ee4dd-ec01-4b65-b4b1-40d44260fc82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LeaseTermOfAmendedLeaseTerminatePeriod_3a36af23-a64b-435f-a1d6-16e0880afb8e" xlink:href="cccc-20221231.xsd#cccc_LeaseTermOfAmendedLeaseTerminatePeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:to="loc_cccc_LeaseTermOfAmendedLeaseTerminatePeriod_3a36af23-a64b-435f-a1d6-16e0880afb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TenantImprovements_b36d6e2b-2d0f-4b5c-8d8c-c5bc309c1ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TenantImprovements"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:to="loc_us-gaap_TenantImprovements_b36d6e2b-2d0f-4b5c-8d8c-c5bc309c1ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_0a5355d3-be14-4a05-a5f2-ed3e6eac8fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:to="loc_us-gaap_RestrictedCash_0a5355d3-be14-4a05-a5f2-ed3e6eac8fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfAmendedLeaseSeparateContracts_2227a4b0-0695-4842-ba7b-cb58c55ea6b5" xlink:href="cccc-20221231.xsd#cccc_NumberOfAmendedLeaseSeparateContracts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_9c50b011-eb92-4389-add3-0ee37e6c14de" xlink:to="loc_cccc_NumberOfAmendedLeaseSeparateContracts_2227a4b0-0695-4842-ba7b-cb58c55ea6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryofleasecostsDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#LeasesSummaryofleasecostsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryofleasecostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ee233ffa-936d-489e-ac67-430c818c42ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_de26a49f-b2fa-401b-b31a-975c39c8579b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ee233ffa-936d-489e-ac67-430c818c42ac" xlink:to="loc_us-gaap_OperatingLeaseCost_de26a49f-b2fa-401b-b31a-975c39c8579b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_2d01119c-9143-4eff-a7dd-0dd85d413ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ee233ffa-936d-489e-ac67-430c818c42ac" xlink:to="loc_us-gaap_VariableLeaseCost_2d01119c-9143-4eff-a7dd-0dd85d413ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_ffdc27bd-82e3-48fc-abca-707346283e96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ee233ffa-936d-489e-ac67-430c818c42ac" xlink:to="loc_us-gaap_SubleaseIncome_ffdc27bd-82e3-48fc-abca-707346283e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_d15eeee1-b848-443a-9b2a-c9348b928a19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ee233ffa-936d-489e-ac67-430c818c42ac" xlink:to="loc_us-gaap_LeaseCost_d15eeee1-b848-443a-9b2a-c9348b928a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryofleasetermandincrementalborrowingrateDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#LeasesSummaryofleasetermandincrementalborrowingrateDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryofleasetermandincrementalborrowingrateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7681b899-577e-4eb7-a5e9-b6ac3d518857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fec5242a-6826-4c99-bf93-b92bd69499e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7681b899-577e-4eb7-a5e9-b6ac3d518857" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fec5242a-6826-4c99-bf93-b92bd69499e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0e8fb4ba-1980-43d9-b0e0-a5121eb7fa3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7681b899-577e-4eb7-a5e9-b6ac3d518857" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0e8fb4ba-1980-43d9-b0e0-a5121eb7fa3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#LeasesSummaryoffutureleasepaymentsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_97c15509-db8a-41a6-8c0a-709fe1c87918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4e53fc44-0b25-4594-9ec3-877027a6dc29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97c15509-db8a-41a6-8c0a-709fe1c87918" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_4e53fc44-0b25-4594-9ec3-877027a6dc29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_059c8fae-5c85-4dfe-bf6e-556a27fc92dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97c15509-db8a-41a6-8c0a-709fe1c87918" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_059c8fae-5c85-4dfe-bf6e-556a27fc92dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_957a1589-66a0-4411-ba83-0764d52d00f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97c15509-db8a-41a6-8c0a-709fe1c87918" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_957a1589-66a0-4411-ba83-0764d52d00f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_659e5672-a778-4727-b612-159bc7035c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97c15509-db8a-41a6-8c0a-709fe1c87918" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_659e5672-a778-4727-b612-159bc7035c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_bc7e3850-e7b0-43eb-8bd8-9ea0698637c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97c15509-db8a-41a6-8c0a-709fe1c87918" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_bc7e3850-e7b0-43eb-8bd8-9ea0698637c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5ae0a361-3d01-4009-b364-269bc9eced0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97c15509-db8a-41a6-8c0a-709fe1c87918" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5ae0a361-3d01-4009-b364-269bc9eced0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ec8c0caa-3997-472a-89f7-38b0ea5fb10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97c15509-db8a-41a6-8c0a-709fe1c87918" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ec8c0caa-3997-472a-89f7-38b0ea5fb10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9c751e87-2660-46df-9f23-5e0fc7d822b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97c15509-db8a-41a6-8c0a-709fe1c87918" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9c751e87-2660-46df-9f23-5e0fc7d822b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_629827b0-4dee-4127-9f93-da5cbfc9cfa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97c15509-db8a-41a6-8c0a-709fe1c87918" xlink:to="loc_us-gaap_OperatingLeaseLiability_629827b0-4dee-4127-9f93-da5cbfc9cfa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails_1" xlink:type="simple" xlink:href="cccc-20221231.xsd#LeasesSummaryoffutureleasepaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LeasesSummaryoffutureleasepaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#AccruedexpensesandothercurrentliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/AccruedexpensesandothercurrentliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_7f7e95b8-2124-4053-9b7e-1a34f9ad2311" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AccruedResearchAndDevelopmentCurrent_13de145a-ef55-42ba-bed4-4c85dcc5ca19" xlink:href="cccc-20221231.xsd#cccc_AccruedResearchAndDevelopmentCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7f7e95b8-2124-4053-9b7e-1a34f9ad2311" xlink:to="loc_cccc_AccruedResearchAndDevelopmentCurrent_13de145a-ef55-42ba-bed4-4c85dcc5ca19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_8c8ef0f9-2754-4725-ae7c-d7660dfb4386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7f7e95b8-2124-4053-9b7e-1a34f9ad2311" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_8c8ef0f9-2754-4725-ae7c-d7660dfb4386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_d2e7cfb0-4b82-46e2-a999-28dcd08666e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7f7e95b8-2124-4053-9b7e-1a34f9ad2311" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_d2e7cfb0-4b82-46e2-a999-28dcd08666e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c5fe550e-2aa0-4ce5-b346-ba970c7dad43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7f7e95b8-2124-4053-9b7e-1a34f9ad2311" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c5fe550e-2aa0-4ce5-b346-ba970c7dad43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_0dbbb7ea-564e-4bd2-902c-0373164d40b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7f7e95b8-2124-4053-9b7e-1a34f9ad2311" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_0dbbb7ea-564e-4bd2-902c-0373164d40b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsNarrativeDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#CollaborationandlicenseagreementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16169b03-160b-4e96-8e9f-3c30cd6d8718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_75a77192-ca7a-4335-b0a3-722b8c44f23e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_16169b03-160b-4e96-8e9f-3c30cd6d8718" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_75a77192-ca7a-4335-b0a3-722b8c44f23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_26a43b2e-a964-430e-b675-aa5468764dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_75a77192-ca7a-4335-b0a3-722b8c44f23e" xlink:to="loc_us-gaap_TypeOfArrangementAxis_26a43b2e-a964-430e-b675-aa5468764dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_938080a5-6fa7-4274-9575-5bb76c2f3151" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_26a43b2e-a964-430e-b675-aa5468764dec" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_938080a5-6fa7-4274-9575-5bb76c2f3151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RestatedRocheAgreementMember_d549c95d-a6a7-4d5b-a58c-33e83c50fa4e" xlink:href="cccc-20221231.xsd#cccc_RestatedRocheAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_938080a5-6fa7-4274-9575-5bb76c2f3151" xlink:to="loc_cccc_RestatedRocheAgreementMember_d549c95d-a6a7-4d5b-a58c-33e83c50fa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenLicenseAgreementMember_4037b55b-0954-46cf-bd82-82d2f5a3d3c8" xlink:href="cccc-20221231.xsd#cccc_BiogenLicenseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_938080a5-6fa7-4274-9575-5bb76c2f3151" xlink:to="loc_cccc_BiogenLicenseAgreementMember_4037b55b-0954-46cf-bd82-82d2f5a3d3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CalicoLicenseAgreementMember_f2c1a14d-28ef-475a-a2fe-2fe7af5be727" xlink:href="cccc-20221231.xsd#cccc_CalicoLicenseAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_938080a5-6fa7-4274-9575-5bb76c2f3151" xlink:to="loc_cccc_CalicoLicenseAgreementMember_f2c1a14d-28ef-475a-a2fe-2fe7af5be727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RestatedRocheAgreementBiogenLicenseAgreementAndCalicoLicenseAgreementMember_3f5710ae-a583-4fb9-a748-fa57278b24c6" xlink:href="cccc-20221231.xsd#cccc_RestatedRocheAgreementBiogenLicenseAgreementAndCalicoLicenseAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_938080a5-6fa7-4274-9575-5bb76c2f3151" xlink:to="loc_cccc_RestatedRocheAgreementBiogenLicenseAgreementAndCalicoLicenseAgreementMember_3f5710ae-a583-4fb9-a748-fa57278b24c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenResearchAndLicenseAgreementMember_d9d3167c-3cca-4087-add9-48b646229b89" xlink:href="cccc-20221231.xsd#cccc_BiogenResearchAndLicenseAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_938080a5-6fa7-4274-9575-5bb76c2f3151" xlink:to="loc_cccc_BiogenResearchAndLicenseAgreementMember_d9d3167c-3cca-4087-add9-48b646229b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2f196123-39d1-4438-81d9-adf538f4684d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_75a77192-ca7a-4335-b0a3-722b8c44f23e" xlink:to="loc_srt_ProductOrServiceAxis_2f196123-39d1-4438-81d9-adf538f4684d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_936929bc-969c-4f12-b957-7f777e6801ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2f196123-39d1-4438-81d9-adf538f4684d" xlink:to="loc_srt_ProductsAndServicesDomain_936929bc-969c-4f12-b957-7f777e6801ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LeadSeriesIdentificationAchievementMember_0478ed95-e809-45e0-9582-2dde8034c3de" xlink:href="cccc-20221231.xsd#cccc_LeadSeriesIdentificationAchievementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_936929bc-969c-4f12-b957-7f777e6801ca" xlink:to="loc_cccc_LeadSeriesIdentificationAchievementMember_0478ed95-e809-45e0-9582-2dde8034c3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_GoodLaboratoryPracticeGlpToxicologyToxStudyPhaseMember_d9cf90f2-a8df-47e5-b485-18944290e547" xlink:href="cccc-20221231.xsd#cccc_GoodLaboratoryPracticeGlpToxicologyToxStudyPhaseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_936929bc-969c-4f12-b957-7f777e6801ca" xlink:to="loc_cccc_GoodLaboratoryPracticeGlpToxicologyToxStudyPhaseMember_d9cf90f2-a8df-47e5-b485-18944290e547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1e6b14ab-9b15-4ea8-9bbb-0c686fcd370b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_75a77192-ca7a-4335-b0a3-722b8c44f23e" xlink:to="loc_srt_RangeAxis_1e6b14ab-9b15-4ea8-9bbb-0c686fcd370b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8e619a78-5044-4ac4-b4b1-5abf4274f1f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1e6b14ab-9b15-4ea8-9bbb-0c686fcd370b" xlink:to="loc_srt_RangeMember_8e619a78-5044-4ac4-b4b1-5abf4274f1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eceaa13f-29aa-4eed-8fd9-8cd9d04a8775" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8e619a78-5044-4ac4-b4b1-5abf4274f1f4" xlink:to="loc_srt_MinimumMember_eceaa13f-29aa-4eed-8fd9-8cd9d04a8775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_e09fe2b9-4240-48e9-8e4f-96cf7d563ac1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8e619a78-5044-4ac4-b4b1-5abf4274f1f4" xlink:to="loc_srt_MaximumMember_e09fe2b9-4240-48e9-8e4f-96cf7d563ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0f21ca45-7bda-4ca6-81b7-dcec1f836ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_75a77192-ca7a-4335-b0a3-722b8c44f23e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0f21ca45-7bda-4ca6-81b7-dcec1f836ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_baf94736-44b6-4281-aaee-118ba3a9491b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_0f21ca45-7bda-4ca6-81b7-dcec1f836ecf" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_baf94736-44b6-4281-aaee-118ba3a9491b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchDevelopmentAndCommercialMilestonePaymentsMember_2a850814-4ed0-4527-bc4a-a302b753581b" xlink:href="cccc-20221231.xsd#cccc_ResearchDevelopmentAndCommercialMilestonePaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_baf94736-44b6-4281-aaee-118ba3a9491b" xlink:to="loc_cccc_ResearchDevelopmentAndCommercialMilestonePaymentsMember_2a850814-4ed0-4527-bc4a-a302b753581b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OneTimeSalesBasedPaymentsMember_d811230a-d22b-40f9-9efe-06a50eba5258" xlink:href="cccc-20221231.xsd#cccc_OneTimeSalesBasedPaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_baf94736-44b6-4281-aaee-118ba3a9491b" xlink:to="loc_cccc_OneTimeSalesBasedPaymentsMember_d811230a-d22b-40f9-9efe-06a50eba5258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentMilestonesMember_21aa878e-664b-463c-8aa3-662867a10738" xlink:href="cccc-20221231.xsd#cccc_ResearchAndDevelopmentMilestonesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_baf94736-44b6-4281-aaee-118ba3a9491b" xlink:to="loc_cccc_ResearchAndDevelopmentMilestonesMember_21aa878e-664b-463c-8aa3-662867a10738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentServicesMember_8dcca173-5910-43f2-bb0d-6fd9f85ba53d" xlink:href="cccc-20221231.xsd#cccc_ResearchAndDevelopmentServicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_baf94736-44b6-4281-aaee-118ba3a9491b" xlink:to="loc_cccc_ResearchAndDevelopmentServicesMember_8dcca173-5910-43f2-bb0d-6fd9f85ba53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_PotentialResearchDevelopmentAndCommercialMilestonePaymentsMember_be8c862e-e543-46f1-a863-428443434f65" xlink:href="cccc-20221231.xsd#cccc_PotentialResearchDevelopmentAndCommercialMilestonePaymentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_baf94736-44b6-4281-aaee-118ba3a9491b" xlink:to="loc_cccc_PotentialResearchDevelopmentAndCommercialMilestonePaymentsMember_be8c862e-e543-46f1-a863-428443434f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_75a77192-ca7a-4335-b0a3-722b8c44f23e" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AdditionalUpfrontConsideration_03b8184d-46f9-4fe3-a4ea-ca5360bc81dd" xlink:href="cccc-20221231.xsd#cccc_AdditionalUpfrontConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_AdditionalUpfrontConsideration_03b8184d-46f9-4fe3-a4ea-ca5360bc81dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfPotentialTargets_85ec0c0d-af0a-453c-a63b-6a86e9a8af33" xlink:href="cccc-20221231.xsd#cccc_NumberOfPotentialTargets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_NumberOfPotentialTargets_85ec0c0d-af0a-453c-a63b-6a86e9a8af33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AnnualResearchPlanPaymentsReceivables_63ec0018-c0b5-4b7d-b53b-03f19cf9391f" xlink:href="cccc-20221231.xsd#cccc_AnnualResearchPlanPaymentsReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_AnnualResearchPlanPaymentsReceivables_63ec0018-c0b5-4b7d-b53b-03f19cf9391f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AnnualResearchPlanPaymentsPeriods_fbea18ae-15d5-4312-866c-5a432b6ef679" xlink:href="cccc-20221231.xsd#cccc_AnnualResearchPlanPaymentsPeriods"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_AnnualResearchPlanPaymentsPeriods_fbea18ae-15d5-4312-866c-5a432b6ef679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_UpfrontFees_eb6584b1-371f-46ea-82da-e4674a1bdaa1" xlink:href="cccc-20221231.xsd#cccc_UpfrontFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_UpfrontFees_eb6584b1-371f-46ea-82da-e4674a1bdaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionExerciseFee_9c81fa63-488d-4647-b621-6639ab5fba11" xlink:href="cccc-20221231.xsd#cccc_OptionExerciseFee"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_OptionExerciseFee_9c81fa63-488d-4647-b621-6639ab5fba11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CollaborativeArrangementOptionExerciseFeesThroughPhase1Trials_81194ac4-48f6-4d60-8b7b-311ffc894b91" xlink:href="cccc-20221231.xsd#cccc_CollaborativeArrangementOptionExerciseFeesThroughPhase1Trials"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_CollaborativeArrangementOptionExerciseFeesThroughPhase1Trials_81194ac4-48f6-4d60-8b7b-311ffc894b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractsReceivableClaimsAndUncertainAmounts_1dd91174-18c2-4a37-b250-93844f1694d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractsReceivableClaimsAndUncertainAmounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_us-gaap_ContractsReceivableClaimsAndUncertainAmounts_1dd91174-18c2-4a37-b250-93844f1694d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NoticePeriodForTerminationOfAgreement_57dc5cde-bf65-4e0a-b16d-77a524649c95" xlink:href="cccc-20221231.xsd#cccc_NoticePeriodForTerminationOfAgreement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_NoticePeriodForTerminationOfAgreement_57dc5cde-bf65-4e0a-b16d-77a524649c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfTargetedProteinDegradation_00fe68a2-09da-43fd-a35c-d4439aabda15" xlink:href="cccc-20221231.xsd#cccc_NumberOfTargetedProteinDegradation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_NumberOfTargetedProteinDegradation_00fe68a2-09da-43fd-a35c-d4439aabda15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentAgreementPeriod_ee238950-7258-473a-b69e-a18c2dff3200" xlink:href="cccc-20221231.xsd#cccc_ResearchAndDevelopmentAgreementPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_ResearchAndDevelopmentAgreementPeriod_ee238950-7258-473a-b69e-a18c2dff3200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NonRefundableUpfrontPayment_00405a27-809c-447b-88d0-459c03a5103a" xlink:href="cccc-20221231.xsd#cccc_NonRefundableUpfrontPayment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_NonRefundableUpfrontPayment_00405a27-809c-447b-88d0-459c03a5103a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_29f08a23-b2a8-4bea-b1c9-3a70a19a5a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_us-gaap_ProceedsFromCollaborators_29f08a23-b2a8-4bea-b1c9-3a70a19a5a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfPerformanceObligation_7cd6b4c8-4d0b-445d-b7f5-0fe9ea8a6122" xlink:href="cccc-20221231.xsd#cccc_NumberOfPerformanceObligation"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_NumberOfPerformanceObligation_7cd6b4c8-4d0b-445d-b7f5-0fe9ea8a6122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfTargets_4fb0b64a-24c4-43a0-a480-61006bae2e6e" xlink:href="cccc-20221231.xsd#cccc_NumberOfTargets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_NumberOfTargets_4fb0b64a-24c4-43a0-a480-61006bae2e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfAdditionalTargets_ea6eca53-724f-4f68-a5ff-07a91f5ac060" xlink:href="cccc-20221231.xsd#cccc_NumberOfAdditionalTargets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_NumberOfAdditionalTargets_ea6eca53-724f-4f68-a5ff-07a91f5ac060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ed48d048-443f-486d-91f8-c8656ea05f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ed48d048-443f-486d-91f8-c8656ea05f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_d1c6adf3-7bee-4a1f-97f1-77e70847a159" xlink:href="cccc-20221231.xsd#cccc_TransactionPriceAllocatedToPerformanceObligation"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_d1c6adf3-7bee-4a1f-97f1-77e70847a159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MilestoneEarnedOnPerformanceObligation_768717da-452c-4b78-b304-37412537b1df" xlink:href="cccc-20221231.xsd#cccc_MilestoneEarnedOnPerformanceObligation"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_MilestoneEarnedOnPerformanceObligation_768717da-452c-4b78-b304-37412537b1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchTerm_8599a973-ec90-4d86-ae90-070eb43a99a7" xlink:href="cccc-20221231.xsd#cccc_ResearchTerm"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_ResearchTerm_8599a973-ec90-4d86-ae90-070eb43a99a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchExtendedTerm_80ad8b45-cb83-454b-97c2-dfb3c720a7ad" xlink:href="cccc-20221231.xsd#cccc_ResearchExtendedTerm"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_ResearchExtendedTerm_80ad8b45-cb83-454b-97c2-dfb3c720a7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AmountPayableForExtendResearchTermOption_ec1de934-cbe4-4cf3-b745-3547e07c9d2b" xlink:href="cccc-20221231.xsd#cccc_AmountPayableForExtendResearchTermOption"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_AmountPayableForExtendResearchTermOption_ec1de934-cbe4-4cf3-b745-3547e07c9d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NumberOfTargetProteins_03f10b17-a407-4ee6-9309-6b0abbd103d1" xlink:href="cccc-20221231.xsd#cccc_NumberOfTargetProteins"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_NumberOfTargetProteins_03f10b17-a407-4ee6-9309-6b0abbd103d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_UpfrontPayment_dec78264-db98-4de7-8df7-ad7d20a2a161" xlink:href="cccc-20221231.xsd#cccc_UpfrontPayment"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_UpfrontPayment_dec78264-db98-4de7-8df7-ad7d20a2a161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AnnualPayments_7153762a-bf08-47e0-b923-622d7661fe65" xlink:href="cccc-20221231.xsd#cccc_AnnualPayments"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_AnnualPayments_7153762a-bf08-47e0-b923-622d7661fe65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_InitialContractualTermOnStraightLineBasis_da57603e-3db1-4e7c-94b2-d89bd3601ad3" xlink:href="cccc-20221231.xsd#cccc_InitialContractualTermOnStraightLineBasis"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_InitialContractualTermOnStraightLineBasis_da57603e-3db1-4e7c-94b2-d89bd3601ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AdditionalTransactionPriceAllocatedToPerformanceObligation_d7013265-9950-4612-8520-981cb712749a" xlink:href="cccc-20221231.xsd#cccc_AdditionalTransactionPriceAllocatedToPerformanceObligation"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_AdditionalTransactionPriceAllocatedToPerformanceObligation_d7013265-9950-4612-8520-981cb712749a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ContractualTerm_fd657cf4-2558-4dfa-9239-ca58f9392bf7" xlink:href="cccc-20221231.xsd#cccc_ContractualTerm"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_d6481774-42b1-44f0-84f8-a5af4b923bb1" xlink:to="loc_cccc_ContractualTerm_fd657cf4-2558-4dfa-9239-ca58f9392bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsAllocationoftotaltransactionpriceandunsatisfiedtransactionpriceDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#CollaborationandlicenseagreementsAllocationoftotaltransactionpriceandunsatisfiedtransactionpriceDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsAllocationoftotaltransactionpriceandunsatisfiedtransactionpriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09209602-c937-45f4-b70d-828d4f622519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_e8905660-81e6-4a31-8789-45abe1a9ec3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_09209602-c937-45f4-b70d-828d4f622519" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_e8905660-81e6-4a31-8789-45abe1a9ec3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_f4485de0-cfe4-4015-83bc-46bce2a72741" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_e8905660-81e6-4a31-8789-45abe1a9ec3e" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_f4485de0-cfe4-4015-83bc-46bce2a72741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4f28d797-57e2-4371-8ab3-5e5b2a50d64f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_f4485de0-cfe4-4015-83bc-46bce2a72741" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4f28d797-57e2-4371-8ab3-5e5b2a50d64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ResearchAndDevelopmentTargetsMember_ebe4c139-b929-40f0-9da6-be4cbab6dcfb" xlink:href="cccc-20221231.xsd#cccc_ResearchAndDevelopmentTargetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4f28d797-57e2-4371-8ab3-5e5b2a50d64f" xlink:to="loc_cccc_ResearchAndDevelopmentTargetsMember_ebe4c139-b929-40f0-9da6-be4cbab6dcfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionRightsMember_b9a10b02-8166-4bf6-a894-ad64743cd78d" xlink:href="cccc-20221231.xsd#cccc_OptionRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_4f28d797-57e2-4371-8ab3-5e5b2a50d64f" xlink:to="loc_cccc_OptionRightsMember_b9a10b02-8166-4bf6-a894-ad64743cd78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_eae3ad45-1fb5-4ce2-b868-0fc98d5ed867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_e8905660-81e6-4a31-8789-45abe1a9ec3e" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_eae3ad45-1fb5-4ce2-b868-0fc98d5ed867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_1552299b-5126-4852-a452-0e9d75b03730" xlink:href="cccc-20221231.xsd#cccc_TransactionPriceAllocatedToPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_eae3ad45-1fb5-4ce2-b868-0fc98d5ed867" xlink:to="loc_cccc_TransactionPriceAllocatedToPerformanceObligation_1552299b-5126-4852-a452-0e9d75b03730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TransactionPriceUnsatisfiedToPerformanceObligation_fe299e74-fd7a-44ac-a0a4-59da18b5d0dc" xlink:href="cccc-20221231.xsd#cccc_TransactionPriceUnsatisfiedToPerformanceObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_eae3ad45-1fb5-4ce2-b868-0fc98d5ed867" xlink:to="loc_cccc_TransactionPriceUnsatisfiedToPerformanceObligation_fe299e74-fd7a-44ac-a0a4-59da18b5d0dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofrevenuefromcollaborationagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_450b631d-12bc-496e-ae0b-f7fe736d0fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_a57d912b-85ae-4eed-860c-a8a762778c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_450b631d-12bc-496e-ae0b-f7fe736d0fed" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_a57d912b-85ae-4eed-860c-a8a762778c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_cebf6be1-3607-49d1-8750-33d481031b01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_a57d912b-85ae-4eed-860c-a8a762778c5d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_cebf6be1-3607-49d1-8750-33d481031b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_563d1c44-81c8-4273-b663-99157d3b9e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_cebf6be1-3607-49d1-8750-33d481031b01" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_563d1c44-81c8-4273-b663-99157d3b9e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RocheAgreementMember_dd6c91bd-6ef9-4ea1-a2bb-b0bfe41b2de8" xlink:href="cccc-20221231.xsd#cccc_RocheAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_563d1c44-81c8-4273-b663-99157d3b9e3b" xlink:to="loc_cccc_RocheAgreementMember_dd6c91bd-6ef9-4ea1-a2bb-b0bfe41b2de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenAgreementMember_8d96319c-bff1-40f9-a63a-f4507070f2f5" xlink:href="cccc-20221231.xsd#cccc_BiogenAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_563d1c44-81c8-4273-b663-99157d3b9e3b" xlink:to="loc_cccc_BiogenAgreementMember_8d96319c-bff1-40f9-a63a-f4507070f2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CalicoAgreementMember_ac9786a8-b859-4445-b691-44f42a80bf48" xlink:href="cccc-20221231.xsd#cccc_CalicoAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_563d1c44-81c8-4273-b663-99157d3b9e3b" xlink:to="loc_cccc_CalicoAgreementMember_ac9786a8-b859-4445-b691-44f42a80bf48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_520a091d-fcf9-4cd8-bbda-089dc6ab463d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_a57d912b-85ae-4eed-860c-a8a762778c5d" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_520a091d-fcf9-4cd8-bbda-089dc6ab463d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6b54ab50-04de-4b53-a643-fe0eb5a42a40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_520a091d-fcf9-4cd8-bbda-089dc6ab463d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6b54ab50-04de-4b53-a643-fe0eb5a42a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleoffinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_99ecade1-ed7c-4455-9f63-70c2e171b747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d30c62d9-03d1-436c-b464-2f4107a7752e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_99ecade1-ed7c-4455-9f63-70c2e171b747" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d30c62d9-03d1-436c-b464-2f4107a7752e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_8e2c62da-5f1d-4791-95b7-55974e8c2217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d30c62d9-03d1-436c-b464-2f4107a7752e" xlink:to="loc_us-gaap_TypeOfArrangementAxis_8e2c62da-5f1d-4791-95b7-55974e8c2217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_29b85bf5-1e7a-41b0-a3cd-947b482cd998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_8e2c62da-5f1d-4791-95b7-55974e8c2217" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_29b85bf5-1e7a-41b0-a3cd-947b482cd998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_RocheAgreementMember_74bc2e6a-96fa-42ad-bbc9-24519e148a81" xlink:href="cccc-20221231.xsd#cccc_RocheAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_29b85bf5-1e7a-41b0-a3cd-947b482cd998" xlink:to="loc_cccc_RocheAgreementMember_74bc2e6a-96fa-42ad-bbc9-24519e148a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_BiogenAgreementMember_16c34559-a5d1-4df0-9036-0678f99a3669" xlink:href="cccc-20221231.xsd#cccc_BiogenAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_29b85bf5-1e7a-41b0-a3cd-947b482cd998" xlink:to="loc_cccc_BiogenAgreementMember_16c34559-a5d1-4df0-9036-0678f99a3669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CalicoAgreementMember_16b45e98-aa65-452c-86d3-fefc76dd6c8c" xlink:href="cccc-20221231.xsd#cccc_CalicoAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_29b85bf5-1e7a-41b0-a3cd-947b482cd998" xlink:to="loc_cccc_CalicoAgreementMember_16b45e98-aa65-452c-86d3-fefc76dd6c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e3aec4e7-dc9c-4e56-8d4c-151cb79cd141" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d30c62d9-03d1-436c-b464-2f4107a7752e" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e3aec4e7-dc9c-4e56-8d4c-151cb79cd141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_b627760f-3e3d-43fb-848c-1b57eadf4de5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e3aec4e7-dc9c-4e56-8d4c-151cb79cd141" xlink:to="loc_us-gaap_ReceivablesNetCurrent_b627760f-3e3d-43fb-848c-1b57eadf4de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_36ccb43f-d236-4a6f-bf0b-8b08485a74a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e3aec4e7-dc9c-4e56-8d4c-151cb79cd141" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_36ccb43f-d236-4a6f-bf0b-8b08485a74a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_baff5c5d-6137-4128-92ed-33f8005782c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e3aec4e7-dc9c-4e56-8d4c-151cb79cd141" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_baff5c5d-6137-4128-92ed-33f8005782c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_a1d10c3c-79b4-43d4-8fff-b1da07035d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_e3aec4e7-dc9c-4e56-8d4c-151cb79cd141" xlink:to="loc_us-gaap_ContractWithCustomerLiability_a1d10c3c-79b4-43d4-8fff-b1da07035d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/CollaborationandlicenseagreementsScheduleofsupplementalfinancialinformationrelatedtocollaborationandlicenseagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03a2d01b-1920-4458-921c-54d5ddfbb694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8167feb5-2821-4314-85f2-2cbf5aa267e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03a2d01b-1920-4458-921c-54d5ddfbb694" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_8167feb5-2821-4314-85f2-2cbf5aa267e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1f09be25-43bc-40a5-b531-1637718ef269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_03a2d01b-1920-4458-921c-54d5ddfbb694" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1f09be25-43bc-40a5-b531-1637718ef269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyNarrativeDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#LongtermdebtandwarrantrelatedpartyNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartyNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d56d45e3-5c60-407f-a95f-595cefd004fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LongTermDebtAndWarrantLiabilityTable_dcf1db28-9aec-43fd-ac62-8fe03d234706" xlink:href="cccc-20221231.xsd#cccc_LongTermDebtAndWarrantLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d56d45e3-5c60-407f-a95f-595cefd004fe" xlink:to="loc_cccc_LongTermDebtAndWarrantLiabilityTable_dcf1db28-9aec-43fd-ac62-8fe03d234706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4590a252-d936-40a0-bbb5-7994dbd3a84a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_dcf1db28-9aec-43fd-ac62-8fe03d234706" xlink:to="loc_us-gaap_CreditFacilityAxis_4590a252-d936-40a0-bbb5-7994dbd3a84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a523d7ed-319f-4d7a-8bfa-d109f8daeb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4590a252-d936-40a0-bbb5-7994dbd3a84a" xlink:to="loc_us-gaap_CreditFacilityDomain_a523d7ed-319f-4d7a-8bfa-d109f8daeb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CreditAgreementWithPerceptiveLifeSciencesMasterFundLTDMember_13835e0c-5288-4ae9-b194-cb7ba4026d89" xlink:href="cccc-20221231.xsd#cccc_CreditAgreementWithPerceptiveLifeSciencesMasterFundLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a523d7ed-319f-4d7a-8bfa-d109f8daeb8f" xlink:to="loc_cccc_CreditAgreementWithPerceptiveLifeSciencesMasterFundLTDMember_13835e0c-5288-4ae9-b194-cb7ba4026d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_03c75fc9-9011-4a66-8544-427205675bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_dcf1db28-9aec-43fd-ac62-8fe03d234706" xlink:to="loc_us-gaap_DebtInstrumentAxis_03c75fc9-9011-4a66-8544-427205675bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_19a6f3ec-2933-4a88-8bcf-6cafc5d0d66e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_03c75fc9-9011-4a66-8544-427205675bce" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_19a6f3ec-2933-4a88-8bcf-6cafc5d0d66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TermLoanMember_f7359713-7ada-4dce-8a78-2359efd7f817" xlink:href="cccc-20221231.xsd#cccc_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_19a6f3ec-2933-4a88-8bcf-6cafc5d0d66e" xlink:to="loc_cccc_TermLoanMember_f7359713-7ada-4dce-8a78-2359efd7f817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f5128ee1-8fb0-4b1a-88f3-cd8f279d9e48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_dcf1db28-9aec-43fd-ac62-8fe03d234706" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f5128ee1-8fb0-4b1a-88f3-cd8f279d9e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6d378c30-2cdf-43fc-9e36-e5f159e03fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f5128ee1-8fb0-4b1a-88f3-cd8f279d9e48" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6d378c30-2cdf-43fc-9e36-e5f159e03fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TrancheOneMember_04ed5820-daff-41d4-8a0f-3af94de2c58c" xlink:href="cccc-20221231.xsd#cccc_TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d378c30-2cdf-43fc-9e36-e5f159e03fcc" xlink:to="loc_cccc_TrancheOneMember_04ed5820-daff-41d4-8a0f-3af94de2c58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TrancheTwoMember_65b799bb-293b-47c1-8076-26a41917bc48" xlink:href="cccc-20221231.xsd#cccc_TrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d378c30-2cdf-43fc-9e36-e5f159e03fcc" xlink:to="loc_cccc_TrancheTwoMember_65b799bb-293b-47c1-8076-26a41917bc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8778d066-e552-4f3e-a57a-e6290ae7736a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_dcf1db28-9aec-43fd-ac62-8fe03d234706" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8778d066-e552-4f3e-a57a-e6290ae7736a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8aaa992b-51ea-4bdc-bb98-4d33cb63febf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8778d066-e552-4f3e-a57a-e6290ae7736a" xlink:to="loc_us-gaap_EquityComponentDomain_8aaa992b-51ea-4bdc-bb98-4d33cb63febf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ff985f2f-ff63-4a27-9504-c77c70482db0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8aaa992b-51ea-4bdc-bb98-4d33cb63febf" xlink:to="loc_us-gaap_CommonStockMember_ff985f2f-ff63-4a27-9504-c77c70482db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d43fcaaf-0ce1-4a5a-913e-8ce5f6773c19" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_dcf1db28-9aec-43fd-ac62-8fe03d234706" xlink:to="loc_srt_RangeAxis_d43fcaaf-0ce1-4a5a-913e-8ce5f6773c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8d6d1561-262d-471c-a869-7ab8ed49b0a3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d43fcaaf-0ce1-4a5a-913e-8ce5f6773c19" xlink:to="loc_srt_RangeMember_8d6d1561-262d-471c-a869-7ab8ed49b0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_47791beb-6afb-4bb9-a0fd-8c47535cc22a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8d6d1561-262d-471c-a869-7ab8ed49b0a3" xlink:to="loc_srt_MinimumMember_47791beb-6afb-4bb9-a0fd-8c47535cc22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dee33113-2716-44ad-9899-981314649616" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8d6d1561-262d-471c-a869-7ab8ed49b0a3" xlink:to="loc_srt_MaximumMember_dee33113-2716-44ad-9899-981314649616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_7be2d302-16ed-483d-81d5-7fecddcd5e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_dcf1db28-9aec-43fd-ac62-8fe03d234706" xlink:to="loc_us-gaap_VariableRateAxis_7be2d302-16ed-483d-81d5-7fecddcd5e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d066d59e-854b-4ae5-a3bb-b0cd7b559bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_7be2d302-16ed-483d-81d5-7fecddcd5e63" xlink:to="loc_us-gaap_VariableRateDomain_d066d59e-854b-4ae5-a3bb-b0cd7b559bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2ce38be8-474e-4b03-a221-752b659c8cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_d066d59e-854b-4ae5-a3bb-b0cd7b559bcd" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_2ce38be8-474e-4b03-a221-752b659c8cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_99c6652a-cd2a-4ee3-a3fd-420e4688a407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_dcf1db28-9aec-43fd-ac62-8fe03d234706" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_99c6652a-cd2a-4ee3-a3fd-420e4688a407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_091e300f-5711-4353-b644-21a089b6a107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_99c6652a-cd2a-4ee3-a3fd-420e4688a407" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_091e300f-5711-4353-b644-21a089b6a107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_647ba7b5-4b37-44b1-96fd-2765a36ea4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_091e300f-5711-4353-b644-21a089b6a107" xlink:to="loc_us-gaap_SubsequentEventMember_647ba7b5-4b37-44b1-96fd-2765a36ea4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:href="cccc-20221231.xsd#cccc_LongTermDebtAndWarrantLiabilityLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityTable_dcf1db28-9aec-43fd-ac62-8fe03d234706" xlink:to="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7ea5c0e-4211-46e0-be86-6c6ee59d31b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7ea5c0e-4211-46e0-be86-6c6ee59d31b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b92dcaae-70fd-4a71-8c5c-7d474e97d01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:to="loc_us-gaap_LineOfCredit_b92dcaae-70fd-4a71-8c5c-7d474e97d01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtInstrumentFloorInterestRate_071086c2-8ffc-4621-914f-7ceebeef9f3a" xlink:href="cccc-20221231.xsd#cccc_DebtInstrumentFloorInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:to="loc_cccc_DebtInstrumentFloorInterestRate_071086c2-8ffc-4621-914f-7ceebeef9f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6e59411b-e506-40f6-8cdc-0a1bfd049651" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_6e59411b-e506-40f6-8cdc-0a1bfd049651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_11830355-3066-49f0-b566-76e00a0dddfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_11830355-3066-49f0-b566-76e00a0dddfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CashBalanceToBeMaintainedInBankAccountWhileDebtIsOutstanding_fe957ce0-6427-43f1-8e60-2c8eade0940f" xlink:href="cccc-20221231.xsd#cccc_CashBalanceToBeMaintainedInBankAccountWhileDebtIsOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:to="loc_cccc_CashBalanceToBeMaintainedInBankAccountWhileDebtIsOutstanding_fe957ce0-6427-43f1-8e60-2c8eade0940f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DebtInstrumentPercentageOfPrincipalPaymentUntilMaturity_3c4d6b61-5f0d-4a23-b8bf-9cdff01fbf2c" xlink:href="cccc-20221231.xsd#cccc_DebtInstrumentPercentageOfPrincipalPaymentUntilMaturity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:to="loc_cccc_DebtInstrumentPercentageOfPrincipalPaymentUntilMaturity_3c4d6b61-5f0d-4a23-b8bf-9cdff01fbf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_3d5828ec-a2f2-49d6-bd08-0769d7c425b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_3d5828ec-a2f2-49d6-bd08-0769d7c425b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_e794256b-964e-4302-88f7-3a87568b53ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_e794256b-964e-4302-88f7-3a87568b53ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_121fd43c-d40c-44ee-884b-d64492d32524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_LongTermDebtAndWarrantLiabilityLineItems_8951c8c1-f174-4084-9966-0aa13fa4ed65" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_121fd43c-d40c-44ee-884b-d64492d32524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartySummaryoffutureminimumpaymentsDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#LongtermdebtandwarrantrelatedpartySummaryoffutureminimumpaymentsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/LongtermdebtandwarrantrelatedpartySummaryoffutureminimumpaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4183c0dc-7f90-4c8d-8204-8f8d49316c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b4428f7f-12be-46c7-9310-d3b0c2b71d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4183c0dc-7f90-4c8d-8204-8f8d49316c15" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b4428f7f-12be-46c7-9310-d3b0c2b71d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ef23dbf3-ce8a-48c4-a170-a453aee4985b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4183c0dc-7f90-4c8d-8204-8f8d49316c15" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ef23dbf3-ce8a-48c4-a170-a453aee4985b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_f888b2d9-a12c-4b51-9fa8-66387ed2686c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4183c0dc-7f90-4c8d-8204-8f8d49316c15" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_f888b2d9-a12c-4b51-9fa8-66387ed2686c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_91768b3e-6a15-49b6-9d55-946833b4479b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4183c0dc-7f90-4c8d-8204-8f8d49316c15" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_91768b3e-6a15-49b6-9d55-946833b4479b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_491cb78a-a8ac-4569-8414-cb5c7be0c3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4183c0dc-7f90-4c8d-8204-8f8d49316c15" xlink:to="loc_us-gaap_LongTermDebt_491cb78a-a8ac-4569-8414-cb5c7be0c3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockholdersequityDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#StockholdersequityDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockholdersequityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e114e081-2716-4927-b8f7-7dc4b0180331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_cebdaae0-28c7-4d77-b72a-f5bf1f2a0d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e114e081-2716-4927-b8f7-7dc4b0180331" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_cebdaae0-28c7-4d77-b72a-f5bf1f2a0d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9eea8d1f-273e-4f4c-bdae-d73b0ff0d781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_cebdaae0-28c7-4d77-b72a-f5bf1f2a0d65" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9eea8d1f-273e-4f4c-bdae-d73b0ff0d781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f5b3febd-d6b0-40bc-9b55-e75d36d6a0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9eea8d1f-273e-4f4c-bdae-d73b0ff0d781" xlink:to="loc_us-gaap_EquityComponentDomain_f5b3febd-d6b0-40bc-9b55-e75d36d6a0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_20d55c56-3a1c-4eae-8a30-d2445eb2d9d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f5b3febd-d6b0-40bc-9b55-e75d36d6a0f9" xlink:to="loc_us-gaap_CommonStockMember_20d55c56-3a1c-4eae-8a30-d2445eb2d9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_01ac8335-ccbc-45ba-91fc-006da2296e49" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_cebdaae0-28c7-4d77-b72a-f5bf1f2a0d65" xlink:to="loc_srt_RangeAxis_01ac8335-ccbc-45ba-91fc-006da2296e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3a9ab849-deeb-45d6-8048-6327ecd28233" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_01ac8335-ccbc-45ba-91fc-006da2296e49" xlink:to="loc_srt_RangeMember_3a9ab849-deeb-45d6-8048-6327ecd28233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f5d32cf8-6f0d-4b42-bfa6-ffd2a7824538" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3a9ab849-deeb-45d6-8048-6327ecd28233" xlink:to="loc_srt_MaximumMember_f5d32cf8-6f0d-4b42-bfa6-ffd2a7824538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_0e636abf-11d1-43f3-b916-990d82085d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_cebdaae0-28c7-4d77-b72a-f5bf1f2a0d65" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_0e636abf-11d1-43f3-b916-990d82085d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84384f79-f5aa-4b80-8888-ad362b73d944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_0e636abf-11d1-43f3-b916-990d82085d20" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84384f79-f5aa-4b80-8888-ad362b73d944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_AtmOfferingsMember_c7e264a3-31fc-4265-bacf-2af35ff8c4a7" xlink:href="cccc-20221231.xsd#cccc_AtmOfferingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84384f79-f5aa-4b80-8888-ad362b73d944" xlink:to="loc_cccc_AtmOfferingsMember_c7e264a3-31fc-4265-bacf-2af35ff8c4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_FollowOnOfferingMember_20c2f4ea-72b3-4c7a-8da0-fa1e948376aa" xlink:href="cccc-20221231.xsd#cccc_FollowOnOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_84384f79-f5aa-4b80-8888-ad362b73d944" xlink:to="loc_cccc_FollowOnOfferingMember_20c2f4ea-72b3-4c7a-8da0-fa1e948376aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_81ac9977-f654-4df6-946f-6471f39c2db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_cebdaae0-28c7-4d77-b72a-f5bf1f2a0d65" xlink:to="loc_us-gaap_TypeOfArrangementAxis_81ac9977-f654-4df6-946f-6471f39c2db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_46e77a82-ee0b-4803-80e5-980ae944c329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_81ac9977-f654-4df6-946f-6471f39c2db9" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_46e77a82-ee0b-4803-80e5-980ae944c329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EquityDistributionAgreementWithCowenAndCompanyLLCMember_a12e7c12-0301-4dfc-8045-712cea53440e" xlink:href="cccc-20221231.xsd#cccc_EquityDistributionAgreementWithCowenAndCompanyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_46e77a82-ee0b-4803-80e5-980ae944c329" xlink:to="loc_cccc_EquityDistributionAgreementWithCowenAndCompanyLLCMember_a12e7c12-0301-4dfc-8045-712cea53440e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e8bff271-62cb-42e8-b39f-c50cb30b78f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_cebdaae0-28c7-4d77-b72a-f5bf1f2a0d65" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e8bff271-62cb-42e8-b39f-c50cb30b78f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_700a2f7c-929e-4bc5-9865-c1cfd9b6db4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_e8bff271-62cb-42e8-b39f-c50cb30b78f0" xlink:to="loc_us-gaap_RelatedPartyDomain_700a2f7c-929e-4bc5-9865-c1cfd9b6db4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_UnderwritersMember_8a71f2c2-e195-4064-bdab-cf2092f029a3" xlink:href="cccc-20221231.xsd#cccc_UnderwritersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_700a2f7c-929e-4bc5-9865-c1cfd9b6db4b" xlink:to="loc_cccc_UnderwritersMember_8a71f2c2-e195-4064-bdab-cf2092f029a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_cebdaae0-28c7-4d77-b72a-f5bf1f2a0d65" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_778bcd27-46a1-4f74-9149-d6f5620a665f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_778bcd27-46a1-4f74-9149-d6f5620a665f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7f1ffeb2-2fb7-43d3-87b5-20513b162a85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7f1ffeb2-2fb7-43d3-87b5-20513b162a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_49943abe-9e58-4643-a9ed-8e64e62386c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_49943abe-9e58-4643-a9ed-8e64e62386c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_41e0f487-52f5-4966-95ad-0874b10e2baa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_41e0f487-52f5-4966-95ad-0874b10e2baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_CommonStockNumberOfVotesEachShare_c2ea82a4-2c5b-44ce-b66c-2f8c04ca2337" xlink:href="cccc-20221231.xsd#cccc_CommonStockNumberOfVotesEachShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_cccc_CommonStockNumberOfVotesEachShare_c2ea82a4-2c5b-44ce-b66c-2f8c04ca2337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c4c641ec-c202-43b0-84a7-1a78448c9e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c4c641ec-c202-43b0-84a7-1a78448c9e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ProceedsFromIssuanceOfFollowOnOffering_9db2892f-6d23-4789-abe3-44bccf7d42f5" xlink:href="cccc-20221231.xsd#cccc_ProceedsFromIssuanceOfFollowOnOffering"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_cccc_ProceedsFromIssuanceOfFollowOnOffering_9db2892f-6d23-4789-abe3-44bccf7d42f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_569e0721-b14c-415d-ac7b-4eefb76fa091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_569e0721-b14c-415d-ac7b-4eefb76fa091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_af7715c2-12ce-455b-bb95-26f05ee6a623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_af7715c2-12ce-455b-bb95-26f05ee6a623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_SharesWithholdEquivalentToAggregateExercisePriceValue_56ca8c8d-9ff8-43e5-b349-c4896ddf9a3f" xlink:href="cccc-20221231.xsd#cccc_SharesWithholdEquivalentToAggregateExercisePriceValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_cccc_SharesWithholdEquivalentToAggregateExercisePriceValue_56ca8c8d-9ff8-43e5-b349-c4896ddf9a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_StockIssuedDuringPeriodSharesWarrantExercisedRelatedParty_be67c7b4-a3d0-4951-bcdf-b77eda2fb680" xlink:href="cccc-20221231.xsd#cccc_StockIssuedDuringPeriodSharesWarrantExercisedRelatedParty"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_cccc_StockIssuedDuringPeriodSharesWarrantExercisedRelatedParty_be67c7b4-a3d0-4951-bcdf-b77eda2fb680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4eb92d63-d3d2-49e7-a66f-1044e6702373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_ec71bdcd-bcd8-4343-8094-7a0781736c89" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_4eb92d63-d3d2-49e7-a66f-1044e6702373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationNarrativeDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#StockbasedcompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_da6e0076-cdb2-4efc-8fb9-49768bd0f9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51317c88-dc4d-4d5f-98cf-09e1daed9c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_da6e0076-cdb2-4efc-8fb9-49768bd0f9a2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51317c88-dc4d-4d5f-98cf-09e1daed9c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6878875f-5649-4bcc-96cd-abdd72b6a548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51317c88-dc4d-4d5f-98cf-09e1daed9c4a" xlink:to="loc_us-gaap_PlanNameAxis_6878875f-5649-4bcc-96cd-abdd72b6a548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1b500f3a-0cae-49e2-901e-b13a101e51ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_6878875f-5649-4bcc-96cd-abdd72b6a548" xlink:to="loc_us-gaap_PlanNameDomain_1b500f3a-0cae-49e2-901e-b13a101e51ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandFifteenIncentiveStockOptionAndGrantPlanMember_84b1a0e0-f83a-4175-978b-08d0414ad7cd" xlink:href="cccc-20221231.xsd#cccc_TwoThousandFifteenIncentiveStockOptionAndGrantPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1b500f3a-0cae-49e2-901e-b13a101e51ec" xlink:to="loc_cccc_TwoThousandFifteenIncentiveStockOptionAndGrantPlanMember_84b1a0e0-f83a-4175-978b-08d0414ad7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_f3ee8cef-fa10-4ef3-8979-0def14e78796" xlink:href="cccc-20221231.xsd#cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1b500f3a-0cae-49e2-901e-b13a101e51ec" xlink:to="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_f3ee8cef-fa10-4ef3-8979-0def14e78796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandTwentyEmployeeStockPurchasePlanMember_c97ef21c-a6e4-46e2-bfe0-d191777e7ff2" xlink:href="cccc-20221231.xsd#cccc_TwoThousandTwentyEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1b500f3a-0cae-49e2-901e-b13a101e51ec" xlink:to="loc_cccc_TwoThousandTwentyEmployeeStockPurchasePlanMember_c97ef21c-a6e4-46e2-bfe0-d191777e7ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_497da070-12d9-4a8b-9e5d-193932438fb4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51317c88-dc4d-4d5f-98cf-09e1daed9c4a" xlink:to="loc_srt_RangeAxis_497da070-12d9-4a8b-9e5d-193932438fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_70bc1182-9449-4a77-a4a4-e482ecbce871" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_497da070-12d9-4a8b-9e5d-193932438fb4" xlink:to="loc_srt_RangeMember_70bc1182-9449-4a77-a4a4-e482ecbce871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0df6de05-078d-48f9-b8a2-ebecc7c552cc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_70bc1182-9449-4a77-a4a4-e482ecbce871" xlink:to="loc_srt_MinimumMember_0df6de05-078d-48f9-b8a2-ebecc7c552cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dafc5914-4a0a-4490-a1dd-bee6a2cfd45a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_70bc1182-9449-4a77-a4a4-e482ecbce871" xlink:to="loc_srt_MaximumMember_dafc5914-4a0a-4490-a1dd-bee6a2cfd45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_061cbc0f-c232-4c1b-b27d-1cce727a1f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51317c88-dc4d-4d5f-98cf-09e1daed9c4a" xlink:to="loc_us-gaap_AwardTypeAxis_061cbc0f-c232-4c1b-b27d-1cce727a1f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ac2b272a-ab32-42ef-9518-20f39456ba82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_061cbc0f-c232-4c1b-b27d-1cce727a1f91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ac2b272a-ab32-42ef-9518-20f39456ba82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e61b3d1a-7728-4a61-8a22-5e591f9752b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ac2b272a-ab32-42ef-9518-20f39456ba82" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e61b3d1a-7728-4a61-8a22-5e591f9752b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6b4ab453-d6c9-4677-a66d-b8e31b4bcdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51317c88-dc4d-4d5f-98cf-09e1daed9c4a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_6b4ab453-d6c9-4677-a66d-b8e31b4bcdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b70ec33a-483f-4eb0-8180-093a81475a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_6b4ab453-d6c9-4677-a66d-b8e31b4bcdb3" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b70ec33a-483f-4eb0-8180-093a81475a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_4ee3410f-8b62-48c8-8a3a-581e35c4bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b70ec33a-483f-4eb0-8180-093a81475a0c" xlink:to="loc_us-gaap_SubsequentEventMember_4ee3410f-8b62-48c8-8a3a-581e35c4bc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_51317c88-dc4d-4d5f-98cf-09e1daed9c4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3ecc5c46-f8c6-4305-94f4-6c64c248a7ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3ecc5c46-f8c6-4305-94f4-6c64c248a7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dfcf8dee-876a-4361-8113-27949cfb4840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dfcf8dee-876a-4361-8113-27949cfb4840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod_2cc7373d-3c14-4152-9e32-b84b748901f8" xlink:href="cccc-20221231.xsd#cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardCliffVestingPeriod_2cc7373d-3c14-4152-9e32-b84b748901f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_346368fd-3f92-466a-97fd-870bee22e823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_346368fd-3f92-466a-97fd-870bee22e823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e6d3b095-83c1-4f63-a763-aa05f286bf59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e6d3b095-83c1-4f63-a763-aa05f286bf59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_PercentageOfOutstandingSharesOfCommonStock_20805b26-2aa9-45bb-9dc1-a196eef60f52" xlink:href="cccc-20221231.xsd#cccc_PercentageOfOutstandingSharesOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_cccc_PercentageOfOutstandingSharesOfCommonStock_20805b26-2aa9-45bb-9dc1-a196eef60f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5ccc3514-b600-41dc-93e2-dc6f19bef3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5ccc3514-b600-41dc-93e2-dc6f19bef3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_50bc44a8-2df1-4a8f-bfd0-d7219192aac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_50bc44a8-2df1-4a8f-bfd0-d7219192aac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ba5e6158-d900-40ba-9432-4fefcd88aa20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ba5e6158-d900-40ba-9432-4fefcd88aa20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ffd05cb1-d3e2-414b-995e-06bfe9fca5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ffd05cb1-d3e2-414b-995e-06bfe9fca5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesIssuablePerVested_a62dea29-7fe4-4ee9-8bce-b3f906816685" xlink:href="cccc-20221231.xsd#cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesIssuablePerVested"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfCommonSharesIssuablePerVested_a62dea29-7fe4-4ee9-8bce-b3f906816685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_MaximumAuthorizedPayrollDeductionPercentageOfEligibleCompensationForEligibleEmployees_b6fc9551-9152-44f8-80cb-9766d51f230a" xlink:href="cccc-20221231.xsd#cccc_MaximumAuthorizedPayrollDeductionPercentageOfEligibleCompensationForEligibleEmployees"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_cccc_MaximumAuthorizedPayrollDeductionPercentageOfEligibleCompensationForEligibleEmployees_b6fc9551-9152-44f8-80cb-9766d51f230a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_50e0e0e6-00aa-4d2f-a2f1-64d93d551f80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_50e0e0e6-00aa-4d2f-a2f1-64d93d551f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualOfferingPeriods_93d42d92-8382-4259-8c66-c27dbc2e0d04" xlink:href="cccc-20221231.xsd#cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualOfferingPeriods"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_cccc_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAnnualOfferingPeriods_93d42d92-8382-4259-8c66-c27dbc2e0d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_892ae1f8-0d93-4f6d-9114-46f7da23d28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e489af20-e97c-4100-8888-9e52e9a0ada1" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_892ae1f8-0d93-4f6d-9114-46f7da23d28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationScheduleofstockbasedcompensationexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fb454d49-5402-4461-a802-df846355cf46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7e23fea8-ade0-4c98-b30e-bbde219194a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fb454d49-5402-4461-a802-df846355cf46" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7e23fea8-ade0-4c98-b30e-bbde219194a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f49a36a7-6c29-4df7-9235-9698b55935cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7e23fea8-ade0-4c98-b30e-bbde219194a4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f49a36a7-6c29-4df7-9235-9698b55935cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e8427949-6fb5-4e82-9706-649a907b9ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f49a36a7-6c29-4df7-9235-9698b55935cf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e8427949-6fb5-4e82-9706-649a907b9ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6c46facf-77ca-4be7-80e1-42fee230e673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e8427949-6fb5-4e82-9706-649a907b9ef5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_6c46facf-77ca-4be7-80e1-42fee230e673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c571c8e3-d714-4d44-859b-0c2d7a382001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e8427949-6fb5-4e82-9706-649a907b9ef5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c571c8e3-d714-4d44-859b-0c2d7a382001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8d61d176-3d32-48dc-a0e2-42834c3f684c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_7e23fea8-ade0-4c98-b30e-bbde219194a4" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8d61d176-3d32-48dc-a0e2-42834c3f684c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5ae1e8f8-12e3-4b38-b766-65589f5c7362" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8d61d176-3d32-48dc-a0e2-42834c3f684c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5ae1e8f8-12e3-4b38-b766-65589f5c7362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationSummaryofstockoptionactivityDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#StockbasedcompensationSummaryofstockoptionactivityDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationSummaryofstockoptionactivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4affc7e4-2cdb-4ba6-bdb8-7c5c9792ba27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_426c1c64-016c-4220-b03b-48b8e7af1a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4affc7e4-2cdb-4ba6-bdb8-7c5c9792ba27" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_426c1c64-016c-4220-b03b-48b8e7af1a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_991881f6-1812-4b50-96f9-8242c1c7bb61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_426c1c64-016c-4220-b03b-48b8e7af1a5b" xlink:to="loc_us-gaap_PlanNameAxis_991881f6-1812-4b50-96f9-8242c1c7bb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4ff88e5d-90e5-4ae1-8680-ba101b6af45e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_991881f6-1812-4b50-96f9-8242c1c7bb61" xlink:to="loc_us-gaap_PlanNameDomain_4ff88e5d-90e5-4ae1-8680-ba101b6af45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_ba29b6a8-a6bf-4412-8d5e-722e10e94bfd" xlink:href="cccc-20221231.xsd#cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4ff88e5d-90e5-4ae1-8680-ba101b6af45e" xlink:to="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_ba29b6a8-a6bf-4412-8d5e-722e10e94bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b3bc847d-c77b-451c-8577-5b9560d43ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_426c1c64-016c-4220-b03b-48b8e7af1a5b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b3bc847d-c77b-451c-8577-5b9560d43ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e0e154ab-3291-4447-b010-95ce1ac34a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b3bc847d-c77b-451c-8577-5b9560d43ee1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e0e154ab-3291-4447-b010-95ce1ac34a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3b3e5c50-b62f-48f5-9ab0-8b57698f6ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e0e154ab-3291-4447-b010-95ce1ac34a3b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3b3e5c50-b62f-48f5-9ab0-8b57698f6ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4ea6ca91-b170-46c7-88c3-ebd5e9d2d30c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e0e154ab-3291-4447-b010-95ce1ac34a3b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4ea6ca91-b170-46c7-88c3-ebd5e9d2d30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_be8d8a45-3219-4962-b5c2-66488524edb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e0e154ab-3291-4447-b010-95ce1ac34a3b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_be8d8a45-3219-4962-b5c2-66488524edb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_82519eb9-5045-49c7-b767-ced786cda7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e0e154ab-3291-4447-b010-95ce1ac34a3b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_82519eb9-5045-49c7-b767-ced786cda7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2c8560a3-4fe2-4128-8bb1-3c18ba324a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e0e154ab-3291-4447-b010-95ce1ac34a3b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2c8560a3-4fe2-4128-8bb1-3c18ba324a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_224b0301-f535-42bf-93f4-734654158b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b3bc847d-c77b-451c-8577-5b9560d43ee1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_224b0301-f535-42bf-93f4-734654158b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c96d005e-ce9d-4630-900c-27aa2fd9349b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b3bc847d-c77b-451c-8577-5b9560d43ee1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_c96d005e-ce9d-4630-900c-27aa2fd9349b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9b59b287-a31e-4fc4-b4d9-922085e20fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b3bc847d-c77b-451c-8577-5b9560d43ee1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9b59b287-a31e-4fc4-b4d9-922085e20fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_88e74af5-5d2e-42bb-a633-1d262cd341ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9b59b287-a31e-4fc4-b4d9-922085e20fef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_88e74af5-5d2e-42bb-a633-1d262cd341ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_814358ba-0305-48dc-bbf5-936675ddf4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9b59b287-a31e-4fc4-b4d9-922085e20fef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_814358ba-0305-48dc-bbf5-936675ddf4e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5c492ce8-9325-45cf-ba06-808083445faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9b59b287-a31e-4fc4-b4d9-922085e20fef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5c492ce8-9325-45cf-ba06-808083445faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f4db5a8a-f933-4afb-808e-5235632aaeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9b59b287-a31e-4fc4-b4d9-922085e20fef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f4db5a8a-f933-4afb-808e-5235632aaeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_de355d66-6c2a-42ea-8237-d6a747d5adfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9b59b287-a31e-4fc4-b4d9-922085e20fef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_de355d66-6c2a-42ea-8237-d6a747d5adfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_97803191-0cbb-47c2-92c1-8bffbeb86b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b3bc847d-c77b-451c-8577-5b9560d43ee1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_97803191-0cbb-47c2-92c1-8bffbeb86b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_bc94b947-43c8-48ca-97ec-ff13c4bf0b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b3bc847d-c77b-451c-8577-5b9560d43ee1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_bc94b947-43c8-48ca-97ec-ff13c4bf0b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_71b335e5-12b6-4f16-850d-7900fb085187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_b3bc847d-c77b-451c-8577-5b9560d43ee1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_71b335e5-12b6-4f16-850d-7900fb085187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8153b129-299f-443e-98b7-0e79a17eb008" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_71b335e5-12b6-4f16-850d-7900fb085187" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_8153b129-299f-443e-98b7-0e79a17eb008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_5d133c9e-0a6f-4dd0-b308-33bd3f9f0269" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_71b335e5-12b6-4f16-850d-7900fb085187" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_5d133c9e-0a6f-4dd0-b308-33bd3f9f0269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1334f98e-74f3-4b81-84b5-5160ef25c1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_71b335e5-12b6-4f16-850d-7900fb085187" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_1334f98e-74f3-4b81-84b5-5160ef25c1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_865ad162-7f98-4ae0-8383-895b5da27bcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_71b335e5-12b6-4f16-850d-7900fb085187" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_865ad162-7f98-4ae0-8383-895b5da27bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1535167f-752a-47d4-83c8-de14eab17cde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_71b335e5-12b6-4f16-850d-7900fb085187" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_1535167f-752a-47d4-83c8-de14eab17cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_11993c36-a70b-42fe-9e8a-2d8d9ac3481f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_71b335e5-12b6-4f16-850d-7900fb085187" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_11993c36-a70b-42fe-9e8a-2d8d9ac3481f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationSummaryofstockoptionactivityotherinformationDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#StockbasedcompensationSummaryofstockoptionactivityotherinformationDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationSummaryofstockoptionactivityotherinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ea417a7f-0865-423d-9f3e-2254a24022f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a4e246a7-d021-4137-91b1-e113b2993f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ea417a7f-0865-423d-9f3e-2254a24022f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a4e246a7-d021-4137-91b1-e113b2993f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ddc0f139-a194-4cf7-821f-63e67fc6498a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a4e246a7-d021-4137-91b1-e113b2993f8b" xlink:to="loc_us-gaap_PlanNameAxis_ddc0f139-a194-4cf7-821f-63e67fc6498a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_364fef8b-97a1-4dc5-bad0-e62253d1b348" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ddc0f139-a194-4cf7-821f-63e67fc6498a" xlink:to="loc_us-gaap_PlanNameDomain_364fef8b-97a1-4dc5-bad0-e62253d1b348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_fa4d8ffc-2b64-4584-bd9b-ea94ea4549a0" xlink:href="cccc-20221231.xsd#cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_364fef8b-97a1-4dc5-bad0-e62253d1b348" xlink:to="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_fa4d8ffc-2b64-4584-bd9b-ea94ea4549a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abd59883-ead3-42ad-b339-ef8533b51a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a4e246a7-d021-4137-91b1-e113b2993f8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abd59883-ead3-42ad-b339-ef8533b51a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9d0aaac5-83a8-4f31-9016-bde9fa5b2b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abd59883-ead3-42ad-b339-ef8533b51a9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9d0aaac5-83a8-4f31-9016-bde9fa5b2b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9a7092c1-eab6-4cbe-87af-05f68ec99732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_abd59883-ead3-42ad-b339-ef8533b51a9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9a7092c1-eab6-4cbe-87af-05f68ec99732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationSummaryofsignificantvaluationassumptionsDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#StockbasedcompensationSummaryofsignificantvaluationassumptionsDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationSummaryofsignificantvaluationassumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eba5f762-3035-4e38-9d3d-e35eaa067722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71b4a8d2-035e-455b-b05f-da46446b7df3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eba5f762-3035-4e38-9d3d-e35eaa067722" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71b4a8d2-035e-455b-b05f-da46446b7df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_31ef24c6-2b5b-4d2b-b0ac-459962d4d6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71b4a8d2-035e-455b-b05f-da46446b7df3" xlink:to="loc_us-gaap_PlanNameAxis_31ef24c6-2b5b-4d2b-b0ac-459962d4d6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8a39d165-a6f0-4f47-ba55-22e7356ffbe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_31ef24c6-2b5b-4d2b-b0ac-459962d4d6e5" xlink:to="loc_us-gaap_PlanNameDomain_8a39d165-a6f0-4f47-ba55-22e7356ffbe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_3d676b0c-99b6-47d7-9d47-4ecff5d6b339" xlink:href="cccc-20221231.xsd#cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8a39d165-a6f0-4f47-ba55-22e7356ffbe1" xlink:to="loc_cccc_TwoThousandAndTwentyStockOptionAndIncentivePlanMember_3d676b0c-99b6-47d7-9d47-4ecff5d6b339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ea2f0f0d-b117-4db1-919c-6065b589f932" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71b4a8d2-035e-455b-b05f-da46446b7df3" xlink:to="loc_srt_RangeAxis_ea2f0f0d-b117-4db1-919c-6065b589f932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a57f80bc-a73d-4f77-9db8-c07b1820e068" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ea2f0f0d-b117-4db1-919c-6065b589f932" xlink:to="loc_srt_RangeMember_a57f80bc-a73d-4f77-9db8-c07b1820e068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_253652f3-ed45-4f40-a519-be66942448e6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a57f80bc-a73d-4f77-9db8-c07b1820e068" xlink:to="loc_srt_MinimumMember_253652f3-ed45-4f40-a519-be66942448e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9c255206-2f79-4328-b220-e7862dc06ccd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a57f80bc-a73d-4f77-9db8-c07b1820e068" xlink:to="loc_srt_MaximumMember_9c255206-2f79-4328-b220-e7862dc06ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba5f16b4-57d1-442f-9b05-a6ae3ab3a228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_71b4a8d2-035e-455b-b05f-da46446b7df3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba5f16b4-57d1-442f-9b05-a6ae3ab3a228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_12f92604-66a5-4ad7-8ecd-27cf91b1827e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba5f16b4-57d1-442f-9b05-a6ae3ab3a228" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_12f92604-66a5-4ad7-8ecd-27cf91b1827e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3dc249a5-a86b-4ad0-a7dd-d4dbb67f383d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba5f16b4-57d1-442f-9b05-a6ae3ab3a228" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3dc249a5-a86b-4ad0-a7dd-d4dbb67f383d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_4a2091b5-d7eb-496b-b246-9f6690c08b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba5f16b4-57d1-442f-9b05-a6ae3ab3a228" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_4a2091b5-d7eb-496b-b246-9f6690c08b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_b006bf7c-8fa7-483d-9086-e24e70727595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba5f16b4-57d1-442f-9b05-a6ae3ab3a228" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_b006bf7c-8fa7-483d-9086-e24e70727595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_aede6125-7beb-40d7-aca5-7f9e6bbbc50e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba5f16b4-57d1-442f-9b05-a6ae3ab3a228" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_aede6125-7beb-40d7-aca5-7f9e6bbbc50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_505e500f-c5bd-4da5-b8e4-532d543837dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ba5f16b4-57d1-442f-9b05-a6ae3ab3a228" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_505e500f-c5bd-4da5-b8e4-532d543837dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/StockbasedcompensationSummaryofRSUactivityDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#StockbasedcompensationSummaryofRSUactivityDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/StockbasedcompensationSummaryofRSUactivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e278482f-23e0-4a3e-aed0-a9a11dd0ba82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d79134a1-05d3-43e0-9cfc-24d35a0643f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e278482f-23e0-4a3e-aed0-a9a11dd0ba82" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d79134a1-05d3-43e0-9cfc-24d35a0643f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1c18834c-4ff5-4a4a-8f8f-d807d256a801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d79134a1-05d3-43e0-9cfc-24d35a0643f0" xlink:to="loc_us-gaap_AwardTypeAxis_1c18834c-4ff5-4a4a-8f8f-d807d256a801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa9d50ac-0237-4023-a46a-57bdf2127f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1c18834c-4ff5-4a4a-8f8f-d807d256a801" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa9d50ac-0237-4023-a46a-57bdf2127f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_19392bef-2641-4269-bcd3-a52db90b0bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa9d50ac-0237-4023-a46a-57bdf2127f38" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_19392bef-2641-4269-bcd3-a52db90b0bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf0c8bde-1ecb-46d9-a767-c445845507c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d79134a1-05d3-43e0-9cfc-24d35a0643f0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf0c8bde-1ecb-46d9-a767-c445845507c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ba77199-fcdd-4b5b-ba58-0dae462a8c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf0c8bde-1ecb-46d9-a767-c445845507c1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ba77199-fcdd-4b5b-ba58-0dae462a8c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b880ee9e-6e7e-46df-a724-13853e157609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ba77199-fcdd-4b5b-ba58-0dae462a8c68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b880ee9e-6e7e-46df-a724-13853e157609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_35e99f65-1a71-491d-9618-7139837db5d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ba77199-fcdd-4b5b-ba58-0dae462a8c68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_35e99f65-1a71-491d-9618-7139837db5d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d840fdb8-ad8a-44f6-b3a2-3df933927c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ba77199-fcdd-4b5b-ba58-0dae462a8c68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d840fdb8-ad8a-44f6-b3a2-3df933927c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6776d84f-5384-4347-b1ac-ac0d7360660c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ba77199-fcdd-4b5b-ba58-0dae462a8c68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6776d84f-5384-4347-b1ac-ac0d7360660c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77b03fba-834f-405f-9470-299c1fc98a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ba77199-fcdd-4b5b-ba58-0dae462a8c68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77b03fba-834f-405f-9470-299c1fc98a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_98a1255e-1864-4dd7-a8f0-0f80001cd22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf0c8bde-1ecb-46d9-a767-c445845507c1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_98a1255e-1864-4dd7-a8f0-0f80001cd22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c5afba56-ddd8-458b-8b54-598d1de0110f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_98a1255e-1864-4dd7-a8f0-0f80001cd22a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c5afba56-ddd8-458b-8b54-598d1de0110f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_322cf223-b58e-42f7-b174-bf6bf7703753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_98a1255e-1864-4dd7-a8f0-0f80001cd22a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_322cf223-b58e-42f7-b174-bf6bf7703753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_22828348-4837-469d-87c8-dfa55cd86599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_98a1255e-1864-4dd7-a8f0-0f80001cd22a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_22828348-4837-469d-87c8-dfa55cd86599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3fc792fb-cd14-4c6c-bc08-e69cb2039d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_98a1255e-1864-4dd7-a8f0-0f80001cd22a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3fc792fb-cd14-4c6c-bc08-e69cb2039d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c1c8d720-e504-4161-b60d-48f5d5bd39eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_98a1255e-1864-4dd7-a8f0-0f80001cd22a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c1c8d720-e504-4161-b60d-48f5d5bd39eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_1ffa8161-6475-4f59-9078-21327efdd0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bf0c8bde-1ecb-46d9-a767-c445845507c1" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_1ffa8161-6475-4f59-9078-21327efdd0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncomeTaxesSummaryofincometaxbenefitexpenseDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#IncomeTaxesSummaryofincometaxbenefitexpenseDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncomeTaxesSummaryofincometaxbenefitexpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bb902900-a89e-4ee4-bab6-1000e4749430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_157a69ac-726e-4fbd-b790-d6fcee73422f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bb902900-a89e-4ee4-bab6-1000e4749430" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_157a69ac-726e-4fbd-b790-d6fcee73422f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f3bc94d1-22de-47a5-9d29-fd5529594b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_157a69ac-726e-4fbd-b790-d6fcee73422f" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f3bc94d1-22de-47a5-9d29-fd5529594b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_bf1e1104-2703-4869-8f4c-0d4ed27bf5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_157a69ac-726e-4fbd-b790-d6fcee73422f" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_bf1e1104-2703-4869-8f4c-0d4ed27bf5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e38d3b56-646f-4642-ac15-b546bf0fb8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_157a69ac-726e-4fbd-b790-d6fcee73422f" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e38d3b56-646f-4642-ac15-b546bf0fb8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_04d2bf51-4a72-440c-b611-04db4594733b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bb902900-a89e-4ee4-bab6-1000e4749430" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_04d2bf51-4a72-440c-b611-04db4594733b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_875edbb9-7b42-424f-8a48-be24d8b13264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_04d2bf51-4a72-440c-b611-04db4594733b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_875edbb9-7b42-424f-8a48-be24d8b13264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c87dc195-3b72-4084-b1ad-b54c1d8f1ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_04d2bf51-4a72-440c-b611-04db4594733b" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c87dc195-3b72-4084-b1ad-b54c1d8f1ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b2b80c85-5788-4ce8-83b8-ffc2516c4c37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bb902900-a89e-4ee4-bab6-1000e4749430" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b2b80c85-5788-4ce8-83b8-ffc2516c4c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncomeTaxesScheduleofeffectiveincometaxratereconciliationDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#IncomeTaxesScheduleofeffectiveincometaxratereconciliationDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncomeTaxesScheduleofeffectiveincometaxratereconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f3b647f4-3bf9-4ded-94ae-8191856bc7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4e0e9216-8115-4c3b-872f-d7967bc29dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f3b647f4-3bf9-4ded-94ae-8191856bc7f4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_4e0e9216-8115-4c3b-872f-d7967bc29dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f5d9c70e-1079-4fac-8a5e-9e58852460e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f3b647f4-3bf9-4ded-94ae-8191856bc7f4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f5d9c70e-1079-4fac-8a5e-9e58852460e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EffectiveIncomeTaxRateReconciliationFederalTaxCredit_e52cb6ba-93b7-4cd5-9b49-654079d8ff86" xlink:href="cccc-20221231.xsd#cccc_EffectiveIncomeTaxRateReconciliationFederalTaxCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f3b647f4-3bf9-4ded-94ae-8191856bc7f4" xlink:to="loc_cccc_EffectiveIncomeTaxRateReconciliationFederalTaxCredit_e52cb6ba-93b7-4cd5-9b49-654079d8ff86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EffectiveIncomeTaxRateReconciliationStateTaxCredit_acf038ba-1fff-4d23-947d-b8a0d6ff40aa" xlink:href="cccc-20221231.xsd#cccc_EffectiveIncomeTaxRateReconciliationStateTaxCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f3b647f4-3bf9-4ded-94ae-8191856bc7f4" xlink:to="loc_cccc_EffectiveIncomeTaxRateReconciliationStateTaxCredit_acf038ba-1fff-4d23-947d-b8a0d6ff40aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_a3468058-759c-40af-83d6-f7ea8bdb6206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f3b647f4-3bf9-4ded-94ae-8191856bc7f4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_a3468058-759c-40af-83d6-f7ea8bdb6206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_efe54d64-5d71-4aff-a056-bd811f715efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f3b647f4-3bf9-4ded-94ae-8191856bc7f4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_efe54d64-5d71-4aff-a056-bd811f715efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1f1167ad-2253-4ca2-bff5-0aa6e0893f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f3b647f4-3bf9-4ded-94ae-8191856bc7f4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_1f1167ad-2253-4ca2-bff5-0aa6e0893f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cc59d5dd-d3fe-4e8c-bb07-6290a8a1acb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f3b647f4-3bf9-4ded-94ae-8191856bc7f4" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cc59d5dd-d3fe-4e8c-bb07-6290a8a1acb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncomeTaxesScheduleofdeferredtaxassetsandliabilitiesDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#IncomeTaxesScheduleofdeferredtaxassetsandliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncomeTaxesScheduleofdeferredtaxassetsandliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_78e51959-7707-437b-aa4a-64272c32256d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78e51959-7707-437b-aa4a-64272c32256d" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_adb89b7a-b1ae-40dc-880c-1ebbd9d87c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_adb89b7a-b1ae-40dc-880c-1ebbd9d87c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_cd2f77c1-2ed7-49cb-9cf3-cd3c1151a41f" xlink:href="cccc-20221231.xsd#cccc_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:to="loc_cccc_DeferredTaxAssetsCapitalizedResearchAndDevelopmentExpenditures_cd2f77c1-2ed7-49cb-9cf3-cd3c1151a41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxAssetsOperatingLeaseLiability_b9a7aa7a-e583-4c52-a205-8bf02ab3b661" xlink:href="cccc-20221231.xsd#cccc_DeferredTaxAssetsOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:to="loc_cccc_DeferredTaxAssetsOperatingLeaseLiability_b9a7aa7a-e583-4c52-a205-8bf02ab3b661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_6170d0e7-0c9e-4fd2-b00b-44dbf34785e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_6170d0e7-0c9e-4fd2-b00b-44dbf34785e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_067f016a-3941-4c95-83a1-0f64c82fd3d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_067f016a-3941-4c95-83a1-0f64c82fd3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ae7b0220-87ae-4653-8df3-1b11d46f617c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ae7b0220-87ae-4653-8df3-1b11d46f617c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_84f843fe-fcbc-4f86-8879-2a33d408a99b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnTradingSecurities_84f843fe-fcbc-4f86-8879-2a33d408a99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxAssetsCapitalizedStartUpCosts_a6b5af37-fb89-42c4-b3b6-969393e35824" xlink:href="cccc-20221231.xsd#cccc_DeferredTaxAssetsCapitalizedStartUpCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:to="loc_cccc_DeferredTaxAssetsCapitalizedStartUpCosts_a6b5af37-fb89-42c4-b3b6-969393e35824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_f74c00fb-5b24-4f3e-839e-09a04fb81175" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_f74c00fb-5b24-4f3e-839e-09a04fb81175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_78a6c21f-8100-4b3f-9838-1dcf536399c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_71fd5ce6-2b48-49c0-8f8a-96954bbfaa6a" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_78a6c21f-8100-4b3f-9838-1dcf536399c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ebcea7d1-bf37-4d08-917b-8b17e4764486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78e51959-7707-437b-aa4a-64272c32256d" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ebcea7d1-bf37-4d08-917b-8b17e4764486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_DeferredTaxLiabilitiesRightOfUseAsset_8c7934ac-f32b-4677-8540-df33b527f3ba" xlink:href="cccc-20221231.xsd#cccc_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ebcea7d1-bf37-4d08-917b-8b17e4764486" xlink:to="loc_cccc_DeferredTaxLiabilitiesRightOfUseAsset_8c7934ac-f32b-4677-8540-df33b527f3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a370f1f1-4fae-41e8-99fd-45678ec56b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_ebcea7d1-bf37-4d08-917b-8b17e4764486" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a370f1f1-4fae-41e8-99fd-45678ec56b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_85dfce8e-1704-47c0-b5d7-08ed3d8b88d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78e51959-7707-437b-aa4a-64272c32256d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_85dfce8e-1704-47c0-b5d7-08ed3d8b88d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_749242a3-b778-43e9-b81a-cb2fe416737a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78e51959-7707-437b-aa4a-64272c32256d" xlink:to="loc_us-gaap_DeferredTaxLiabilities_749242a3-b778-43e9-b81a-cb2fe416737a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9b3567c5-4299-4c2d-a716-9f826b20a958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_IncomeTaxTable_91fc9bf4-bd04-479a-bc97-c2257810443c" xlink:href="cccc-20221231.xsd#cccc_IncomeTaxTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9b3567c5-4299-4c2d-a716-9f826b20a958" xlink:to="loc_cccc_IncomeTaxTable_91fc9bf4-bd04-479a-bc97-c2257810443c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_891155b5-9b4c-4be3-bd5b-855eb50f56a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxTable_91fc9bf4-bd04-479a-bc97-c2257810443c" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_891155b5-9b4c-4be3-bd5b-855eb50f56a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b7245dde-9d08-4a1a-987e-ffefefb6dddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_891155b5-9b4c-4be3-bd5b-855eb50f56a1" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b7245dde-9d08-4a1a-987e-ffefefb6dddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_c6ab0fed-9a2b-45df-8408-561a6c28efeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b7245dde-9d08-4a1a-987e-ffefefb6dddc" xlink:to="loc_us-gaap_DomesticCountryMember_c6ab0fed-9a2b-45df-8408-561a6c28efeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_3a7de79a-b58f-4f43-ab35-5b3366c19f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b7245dde-9d08-4a1a-987e-ffefefb6dddc" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_3a7de79a-b58f-4f43-ab35-5b3366c19f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_ecd962d6-6118-416f-a1e6-dfd981fe0831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxTable_91fc9bf4-bd04-479a-bc97-c2257810443c" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_ecd962d6-6118-416f-a1e6-dfd981fe0831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_5665b363-cc5e-46a4-afe0-0aa6134f09e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_ecd962d6-6118-416f-a1e6-dfd981fe0831" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_5665b363-cc5e-46a4-afe0-0aa6134f09e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchMember_8bfcf3c6-6e1f-4edb-a28d-5fbe92cb4414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_5665b363-cc5e-46a4-afe0-0aa6134f09e1" xlink:to="loc_us-gaap_ResearchMember_8bfcf3c6-6e1f-4edb-a28d-5fbe92cb4414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_00d12c4e-2fd2-4858-8532-7d8b54014553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxTable_91fc9bf4-bd04-479a-bc97-c2257810443c" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_00d12c4e-2fd2-4858-8532-7d8b54014553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_ff388b54-7679-424a-ab58-ee05af8847e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_00d12c4e-2fd2-4858-8532-7d8b54014553" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_ff388b54-7679-424a-ab58-ee05af8847e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_a123090d-b584-4dd3-bd9d-55a6adad2a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_ff388b54-7679-424a-ab58-ee05af8847e8" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_a123090d-b584-4dd3-bd9d-55a6adad2a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:href="cccc-20221231.xsd#cccc_IncomeTaxLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxTable_91fc9bf4-bd04-479a-bc97-c2257810443c" xlink:to="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7697baa0-7e4c-47fd-b626-8381b893772f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7697baa0-7e4c-47fd-b626-8381b893772f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_ed47ebf7-81d6-44bc-9db0-9ebf7173af6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_ed47ebf7-81d6-44bc-9db0-9ebf7173af6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_4ef3bed6-6761-4bb2-9500-3b707b05d4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_4ef3bed6-6761-4bb2-9500-3b707b05d4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_48fb311b-9d3a-409e-b0c7-ead078ee7765" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_48fb311b-9d3a-409e-b0c7-ead078ee7765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActPercent_b3cfb4df-8e39-4edc-8c2d-67e1ca676588" xlink:href="cccc-20221231.xsd#cccc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:to="loc_cccc_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActPercent_b3cfb4df-8e39-4edc-8c2d-67e1ca676588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_945ef1b7-329a-4cb9-bd14-3c775a7a0587" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_945ef1b7-329a-4cb9-bd14-3c775a7a0587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_072ceb5b-58cd-4cd4-bb15-c46149060f58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_072ceb5b-58cd-4cd4-bb15-c46149060f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_NetOperatingLossCarryforwardsLimitedAndExpiredDueToOwnershipChanges_f1d7733e-d139-42ca-b6d7-7d13fa237ec3" xlink:href="cccc-20221231.xsd#cccc_NetOperatingLossCarryforwardsLimitedAndExpiredDueToOwnershipChanges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:to="loc_cccc_NetOperatingLossCarryforwardsLimitedAndExpiredDueToOwnershipChanges_f1d7733e-d139-42ca-b6d7-7d13fa237ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ebd088fc-1282-46f8-aa0f-d0349177a951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cccc_IncomeTaxLineItems_47ab5d88-69a0-4d33-95ce-21bbdb04b5b8" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_ebd088fc-1282-46f8-aa0f-d0349177a951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/NetLosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#NetLosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/NetLosspershareScheduleofantidilutivesecuritiesexcludedfromcomputationofearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0be67fa6-cd48-427b-8907-edb8893d1a80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_11267624-4bb6-469a-b076-a04a5763e4f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0be67fa6-cd48-427b-8907-edb8893d1a80" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_11267624-4bb6-469a-b076-a04a5763e4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5e606fe8-90dd-4185-89fc-284851596b26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_11267624-4bb6-469a-b076-a04a5763e4f8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5e606fe8-90dd-4185-89fc-284851596b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a7c11965-e3da-4800-9980-a02fee27055c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5e606fe8-90dd-4185-89fc-284851596b26" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a7c11965-e3da-4800-9980-a02fee27055c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cccc_OptionsToPurchaseCommonStockMember_244a177c-6d0e-4b19-a457-69c9aa018bd9" xlink:href="cccc-20221231.xsd#cccc_OptionsToPurchaseCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a7c11965-e3da-4800-9980-a02fee27055c" xlink:to="loc_cccc_OptionsToPurchaseCommonStockMember_244a177c-6d0e-4b19-a457-69c9aa018bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6cd030fa-c423-4091-85e1-a5ec0ed32026" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_11267624-4bb6-469a-b076-a04a5763e4f8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6cd030fa-c423-4091-85e1-a5ec0ed32026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d413844c-b548-47ab-a385-6630d11be53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6cd030fa-c423-4091-85e1-a5ec0ed32026" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d413844c-b548-47ab-a385-6630d11be53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/NetLosspershareScheduleofbasicanddilutedlosspershareDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#NetLosspershareScheduleofbasicanddilutedlosspershareDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/NetLosspershareScheduleofbasicanddilutedlosspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bec4689c-4610-4594-9521-3e2b1b10ae6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a69af3bb-51cf-4aae-8d23-4998fea168ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bec4689c-4610-4594-9521-3e2b1b10ae6c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a69af3bb-51cf-4aae-8d23-4998fea168ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f6802bdb-8593-4578-a228-86657d476cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_a69af3bb-51cf-4aae-8d23-4998fea168ca" xlink:to="loc_us-gaap_NetIncomeLoss_f6802bdb-8593-4578-a228-86657d476cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5d67a514-960b-4b13-86d7-587d2e2f2158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bec4689c-4610-4594-9521-3e2b1b10ae6c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5d67a514-960b-4b13-86d7-587d2e2f2158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6b27c37c-df6e-4733-afcc-1f3a206ca54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5d67a514-960b-4b13-86d7-587d2e2f2158" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6b27c37c-df6e-4733-afcc-1f3a206ca54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bdb0e9f7-cea6-40d8-87d6-ea8d4c8b3d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5d67a514-960b-4b13-86d7-587d2e2f2158" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bdb0e9f7-cea6-40d8-87d6-ea8d4c8b3d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2986b8a6-d4e6-46d9-b4c2-bb50f8ce9707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bec4689c-4610-4594-9521-3e2b1b10ae6c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2986b8a6-d4e6-46d9-b4c2-bb50f8ce9707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3d7332fb-5ba1-4a5f-a937-4c78509f722e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bec4689c-4610-4594-9521-3e2b1b10ae6c" xlink:to="loc_us-gaap_EarningsPerShareBasic_3d7332fb-5ba1-4a5f-a937-4c78509f722e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://c4therapeutics.com/role/DefinedcontributionplanDetails" xlink:type="simple" xlink:href="cccc-20221231.xsd#DefinedcontributionplanDetails"/>
  <link:presentationLink xlink:role="http://c4therapeutics.com/role/DefinedcontributionplanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_55b8be4f-9265-45e6-8769-214a44e2cd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_ca02a3aa-b941-49e7-b985-8eb588ca3a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_55b8be4f-9265-45e6-8769-214a44e2cd0c" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_ca02a3aa-b941-49e7-b985-8eb588ca3a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_e0626057-4848-4d45-abde-809c0d0f8aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_55b8be4f-9265-45e6-8769-214a44e2cd0c" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_e0626057-4848-4d45-abde-809c0d0f8aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_6e871e55-519f-47b8-822e-a1c5ab92724d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_55b8be4f-9265-45e6-8769-214a44e2cd0c" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_6e871e55-519f-47b8-822e-a1c5ab92724d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
